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Abstract
Large amounts of biological data are continuously generated nowadays, thanks to the
advancements of high-throughput experimental techniques. Mining valuable
knowledge from such data still motivates the design of suitable computational
methods, to complement the experimental work which is often bound by
considerable time and cost requirements. Protein complexes, or groups of interacting
proteins, are key players in most cellular events. The identification of complexes not
only allows to better understand normal biological processes but also to uncover
disease-triggering malfunctions. Ultimately, findings in this research branch can
highly enhance the design of effective medical treatments. The aim of this research is
to detect protein complexes in protein-protein interaction networks and to associate
the detected entities to diseases. The work is divided into three main objectives: first,
develop a suitable method for the identification of protein complexes in static
interaction networks; second, model the dynamic aspect of protein interaction
networks and detect complexes accordingly; and third, design a learning model to
link proteins, and subsequently protein complexes, to diseases. In response to these
objectives, we present, ProRank+, a novel complex-detection approach based on a
ranking algorithm and a merging procedure. Then, we introduce DyCluster, which
uses gene expression data, to model the dynamics of the interaction networks, and we
adapt the detection algorithm accordingly. Finally, we integrate network topology
attributes and several biological features of proteins to form a classification model
for gene-disease association. The reliability of the proposed methods is supported by
various experimental studies conducted to compare them with existing approaches.
ProRank+ detects more protein complexes than other state-of-the-art methods.
DyCluster goes a step further and achieves a better performance than similar
techniques. Then, our learning model shows that combining topological and
biological features can greatly enhance the gene-disease association process. Finally,
we present a comprehensive case study of breast cancer in which we pinpoint disease
genes using our learning model; subsequently, we detect favorable groupings of
those genes in a protein interaction network using the ProRank+ algorithm.
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Keywords: Protein-protein interactions, protein complex, gene expression,
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)Title and Abstract (in Arabic

دراسة الشبكات البيولوجية بهدف الكشف عن المركبات البروتينية وربط الجينات
باألمراض
الملخص

يتم توليد كميات كبيرة من البيانات البيولوجية في الوقت الحاضر وذلك بفضل تقدّم
التقنيات التجريبية ذات اإلنتاجية العالية .ما زال استخراج معلومات قيّمة من هذه البيانات يحفز
تصميم طرق حاسوبية مناسبة ،الستكمال العمل التجريبي المرتهن غالبا ً بوقت طويل ومتطلبات
ي في معظم
الكلفة .المركبات البروتينية ،أو مجموعات البروتينات المتفاعلة هي العب أساس ّ
األحداث الخلوية .ال يسمح تحديد المركبات بفهم العمليات البيولوجية العادية بشكل أفضل فحسب
بل أيضا ً بالكشف عن االختالالت المسببة لألمراض .في النهاية ،تستطيع نتائج فرع البحث هذا
تحسين تصميم العالجات الطبية الفعالة إلى حد كبير .هدف هذا البحث الكشف عن المركبات
البروتينية في شبكات تفاعل البروتينات مع بعضها البعض وربط الكيانات المكتشفة باألمراض.
سم إلى  3أهداف رئيسية :أوالً ،تطوير طريقة مناسبة لتحديد المركبات البروتينية
إن العمل مق ّ
في شبكات تفاعل ثابتة .ثانياً ،صياغة الجانب الديناميكي لشبكات تفاعل البروتينات واستبيان
المركبات وفقا ً لذلك .ثالثاً ،تصميم نموذج تعلّم حاسوبي لربط البروتينات وبالتالي المركبات
البروتينية ،باألمراض .ردا ً على هذه األهداف ،نقد ّم برورانك ،+وهو أسلوب جديد في تحديد
ي على خوارزمية لتصنيف المركبات وترتيبها ودمجها .ثم ندخل دايكلستر ،الذي
المركبات مبن ّ
يستخدم بيانات التعبير الجيني لصياغة ديناميات شبكات التفاعل ونكيّف خوارزمية الكشف وفقا ً
لذلك .أخيراً ،ندمج الصفات الطوبولوجية لشبكة البروتينات في سمات البروتينات البيولوجية
لتشكيل نموذج تصنيف لربط الجينات باألمراض .مصداقية الطرق المقترحة مدعومة بدراسات
تجريبية متنوعة أجريت لمقارنتها مع أساليب قائمة .يكشف برورانك +عن مركبات بروتينية
ي أساليب متطورة أخرى .يذهب دايكلستر خطوة أبعد ويحقق أدا ًء أفضل من أداء
أكثر من أ ّ
تقنيات مشابهة .ثم يظهر نموذج التعلّم الخاص بنا أن الجمع بين السمات الطوبولوجية والسمات
سن إلى حد كبير عملية ربط الجينات باألمراض .أخيراً ،نقدّم دراسة
البيولوجية يستطيع أن يح ّ
شاملة لحالة سرطان الثدي نحدد فيها جينات المرض مستخدمين نموذج التعلّم الخاص بنا .من ثم

x

نحدد التجمعات المناسبة لتلك الجينات في شبكة تفاعل البروتينات مستخدمين خوارزومية
برورانك.+
مفاهيم البحث الرئيسية :تفاعل البروتينات مع بعضها البعض ،المركبات البروتينية ،التعبير
الجيني ،السمات الطوبولوجية ،السمات البيولوجية ،ربط الجينات باألمراض.
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Chapter 1: Introduction
1.1 Scope
From metabolism, signal transduction, transport, cellular organization to most
biological processes, proteins are the key players. Their interconnections shape
interaction networks which define highly-organized cellular systems (1000 Genomes
Project Consortium, 2010). The association of a gene or a complex to a certain
biological function broadens our perception of how this function occurs and it
consequently allows us to uncover the malfunctions that trigger various diseases. For
instance, in terms of a normal phenomenon, happiness can be psychologically
defined as “the experience of joy, contentment, or positive well-being, combined
with a sense that one’s life is good, meaningful, and worthwhile” (Lyubomirsky,
2008). Philosophically, according to Aristotle, “Happiness depends upon ourselves”.
Genetically, legitimate questions are asked: How far does happiness really depend on
“ourselves”? Do genes, the shaping elements of “ourselves”, contribute to our
happiness? In fact, genetics are linked to individual life satisfaction and particularly
to happiness: long and more efficient alleles of the serotonin transporter gene 5HTTLPR and self-reported life satisfaction are positively associated (De Neve,
Christakis, Fowler, & Frey, 2012). In view of that, a recent study (Oswald & Proto,
2013) measures the genetic distance among countries’ populations and finds that it is
highly correlated with international well-being differences. On the other hand, in
terms of identifying disease-related genes, in ancient history, cancers were blamed on
the gods (The History of Cancer, 2015). Then, through the middle ages, it was
associated to imbalances in the body. Various theories were proposed later ranging
from the lymph theory in the 1700s to the trauma theory and the infectious disease
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theory in the 17th and the 18th centuries. Accumulated knowledge in genetics
throughout the following years allowed more understanding of the disease. In 2014,
more than 100 chemical, physical and biological substances were associated by the
World Health Organization to cancer (World Health Organization IARC, 2014). In
the same year, breast cancer was listed as the highest occurring cancer type in
women worldwide (World Health Organization, 2014). The earlier association of the
BRCA1 gene to breast cancer (Miki et al., 1994) not only accelerated the design of
more efficacious treatments but also allowed the discovery of many key genes and
complexes in other cancer types and complex diseases.
Looking at the bigger picture, every genetic finding can be viewed as a
puzzle piece that contributes to our comprehension of various molecular functions as
well as different disorders. Ultimately, the more we know, the more we are able to
improve medical treatments.
1.2 Background
The deoxyribonucleic acid (DNA) is considered the cell’s “master molecule”
thanks to its essential functional properties (Lodish et al., 2013). It has a double-helix
structure composed by two helical strands coiled around a common axis (Watson &
Crick, Molecular structure of nucleic acids, 1953). This structure allows transferring
genetic characteristics among successive generations and is thus crucial to heredity.
The DNA strands consist of four types of nucleotides: adenine (A), thymine (T),
cytosine (C) and guanine (G). They are arranged in such a way that A on one strand
is matched with T on the other strand and likewise, C is matched with G. The linear
order of nucleotides along each strand defines the genetic information carried by
DNA. The informative segments of DNA are divided into functional units called
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genes which typically consist of 5,000 to 100,000 nucleotides. Many genes are
responsible for making proteins, the primary molecules defining cellular structure
and activities. The conversion of DNA into proteins is divided into two processes as
presented in Figure 1. The first process is transcription by which the coding portion
of a gene is copied into a single-stranded ribonucleic acid (RNA) version of DNA. A
large enzyme called RNA polymerase uses DNA as a template and catalyzes the
linkage of nucleotides into RNA chain. In eukaryotic cells, RNA is transformed into
a smaller messenger RNA (mRNA) molecule which moves to the cytoplasm region
of the cell. This is where the second process, known as translation, takes place. A
very complex molecular machine called ribosome and composed of both RNA and

Figure 1: The multi-process conversion of DNA into protein (Lodish et
al., 2013).
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protein comes into play. The ribosome assembles amino acids to form proteins
exactly as inferred by the mRNA sequence. Proteins consist of linear chains in which
20 different amino acids can be combined. Once a chain is created, it folds to form a
three-dimensional structure which determines its distinctive function, as shown in
Figure 2. The linear amino acid sequence of a protein (primary structure) folds into
helices (secondary structure) that pack into globular domains (tertiary structure).
Some proteins self-associate into complexes (quaternary structure) which comprise
tens to hundreds subunits (supramolecular assemblies). Proteins can exhibit various
functions including regulation, structure, movement, catalysis, transport and
signaling. All those functions are subject to proper protein folding. The types and
amounts of mRNA molecules existing in a cell determine its function. Accordingly,
the course of protein formation through transcription and translation critically defines
the functions of cells (O'Connor, Adams, & Fairman, 2010). The regulation of those

Figure 2: Protein structure and function (Lodish et al., 2013).
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processes allows cells to respond to environmental variations. In the same context,
we note here that genes which exhibit similar expression patterns across various
environmental conditions most likely interact (Baldi & Hatfield, 2002).

Figure 3: The structural levels of proteins
(Wikimedia Commons, 2008).
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Figure 3 visualizes the four structure levels of a protein, from amino acid
sequence to protein complex. Mutations are errors that occur during DNA
replication. It alters the nucleotide sequence by changing its order, deleting or
inserting an element, or even inverting it. This can cause the abnormal generation of
proteins and can lead to inherited diseases if not controlled properly. For example,
the sickle cell disease is caused by a single mutation of the hemoglobin gene by
which the 17th nucleotide is changed from T to A (Rees, Williams, & Gladwin,
2010). In view of that, identifying disease-causing mutations and subsequently,
disease-related genes, protein and protein complexes is indeed a crucial task towards
understanding various disorders and finding suitable ways to possibly avoid or treat
them.
1.3 Motivation and Problem Statement
Biological functions are often acquired through collaborations of interacting
protein groups referred to as protein complexes (Gavin et al., 2006). High-throughput
experimental techniques designed to study protein complexes, such as yeast twohybrid (Y2H) (Fields & Song, 1989) and tandem affinity purification (TAP-MS)
(Collins & Choudhary, 2008) approaches, are generally time-consuming and costly.
Moreover, they are susceptible to high error rates (Marto, 2009). In view of that,
various computational methods are developed to complement and reduce the efforts
required for biological explorations. Ideally, looking at protein-protein interaction
(PPI) data, a reliable computational approach can identify proteins and subsequently
protein complexes possibly engaged in certain functions or phenotypes, for further
experimental examinations. It is believed that the more enrichment with biological
information is added to interaction networks and complex-detection algorithms, the
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better is the overall quality of the results. In a computational context, a PPI dataset is
usually modeled as a single graph in which vertices and edges represent the proteins
and their interconnections, respectively. An example of a protein complex is shown
in Figure 4 in terms of graph and structural representations based on the work by
(Newman, Brändén, & Jones, 1993) and visualized at the Protein Data Bank (Berman
et al., 2000).
Given a PPI dataset, the goal is to develop a suitable computational approach
that can identify the corresponding protein complexes and subsequently associate the
detected entities to diseases. In this direction, several challenges need to be
addressed. First, experimentally-generated datasets are usually large. For instance, in
the case of human PPIs, the June 2015 release of the BioGRID repository (Stark et
al., 2006) contains 186744 non-redundant interactions among 19415 unique proteins.
As a result, scalable and efficient methods are required for their analysis. In addition,
PPI data may contain false positive (spuriously-detected) and false negative

(b)
(a)

Figure 4: An example of a protein complex. (a) A graph
representation in which nodes and edges represent
protein and their interactions, respectively. (b) The
biological assembly of the complex.
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(missing) interactions. Consequently, suitable data cleaning techniques have to be
applied prior to analysis in order to ensure the reliability of the results. Moreover,
protein interactions do not occur simultaneously. They are subject to temporal,
spatial and contextual conditions (Macropol, Can, & Singh, 2009). Accordingly, the
comprehensive network representation of a PPI dataset ought to take the dynamic
nature of interactions into consideration. These main challenges, among others,
constitute the focus points based on which our methodology is designed and
developed.
1.4 Research Objectives and Proposed Solutions
The goal of this dissertation is to develop a suitable approach for the
identification and association of proteins and protein complexes to diseases. In this
direction, the work is divided into three main objectives:
1- Detecting protein complexes in PPI networks.
2- Modeling the dynamic aspect of PPI networks and detecting protein
complexes accordingly.
3- Developing a learning model to classify genes as disease-related or
not.
To begin, we introduce ProRank+ (Hanna & Zaki, 2014), a protein-complex
detection method based on a ranking algorithm which sorts proteins according to
their importance in the PPI network; and a merging procedure which refines the
detected complexes in terms of their members. When compared to several state-ofthe-art approaches, ProRank+ is able to detect more protein complexes with higher
quality scores.
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Since protein interaction networks are dynamic in nature (Levy & PereiraLeal, 2008), our second objective is to model the dynamic aspect of PPI networks
and to tune ProRank+ accordingly. Recent experimental tools, such as ChIP-chip
(Kim & Ren, 2006) and ChIP-seq (Johnson, Mortazavi, Myers, & Wold, 2007), can
provide temporal, spatial and contextual information across which PPIs occur.
Consequently, advances in computational approaches developed to analyze PPI
networks ought to relate to such diversity of information which is currently available.
Gene expression datasets consist of quantitative measurements of genes in cellular
compartments across different conditions (Lovén et al., 2012). Genome-wide
expression levels can now be studied (Secrier & Schneider, 2013). Genes with
correlated expressions across subsets of conditions most likely interact (Baldi &
Hatfield, 2002). As a result, the integration of gene expression data with PPI
information can potentially reveal the processes which underline the formation of
protein complexes. In this direction, we present DyCluster, a framework to model the
dynamic aspect of protein interaction networks by incorporating gene expression
data, through biclustering techniques (Busygin, Prokopyev, & Pardalos, 2008), prior
to applying complex-detection algorithms. The experimental studies, including
biological applications, show that DyCluster leads to high numbers of correctly
detected complexes with better evaluation scores.
The last objective consists of designing a suitable approach for gene-disease
association. We propose a learning model which integrates PPI network topology
features and biological information collected from various sources. A learning
model, here classification model, given training data (data objects whose class label
is known), consists of a set of functions that can describe and distinguish data
classes. Such model can then be used to predict the class of objects whose class label
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is unknown. Given a list of genes, the goal is to maximize the contrast between
disease and non-disease classes. Accordingly, we study the topology of the
corresponding PPI network to find distinctive positioning of genes in interaction
networks. Then, we combine those features with biological data from various sources
to uncover potential similarities which characterize each class. The experimental
work strongly favors our approach.
1.5 Dissertation Outline
The dissertation is organized as follows. In chapter 2, we survey and discuss
state-of-the-art methods related to our research objectives. Chapter 3 introduces our
method for the detection of protein complexes in PPI networks. In chapter 4, we
present our approach to model dynamic protein interaction networks and
subsequently detect complexes. Chapter 5 includes our solution for gene-disease
association. A comprehensive case study of the breast cancer disease is presented in
chapter 6. Finally, we conclude the dissertation in chapter 7.
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Chapter 2: Related Work
This chapter surveys the state-of-the-art approaches related to our research
objectives. Computational methods developed for the detection of protein complexes
in PPI networks are reviewed in section 2.1. Various ways to model the dynamic
aspect of PPI networks and detect protein complexes accordingly are presented in
section 2.2. Gene-disease association approaches are discussed in section 2.3. Lastly,
the drawbacks of previous approaches that we seek to overcome in our work are
summarized in section 2.4.
2.1 Detecting Protein Complexes in Protein-Protein Interaction Networks
In a computational setting, it is generally assumed that protein complexes
correspond to dense subgraphs in PPI networks. We hereafter highlight state-of-theart methods for the detection of complexes in protein interaction networks. The
Markov Clustering algorithm (MCL) (Van Dongen, 2001) looks for cluster structures
in protein interaction networks using random walks. The search is based on
alternations between two main operators: expansion which is given by taking the
power of a stochastic matrix using matrix squaring; and inflation which corresponds
to taking the Hadamard power of a matrix, i.e. entry-wise, followed by a scaling step,
to generate a stochastic matrix. The algorithm deterministically calculates the
probabilities of random walks in the network and transforms one set of probabilities
into another based on the expansion and inflation operators. The Molecular Complex
Detection (MCODE) algorithm (Bader & Hogue, 2003) identifies complexes as
dense regions grown from highly-weighted vertices. A vertex is weighted by
checking the highest k-core in its neighbourhood, i.e. the central most densely
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connected subgraph of minimal degree k. MCODE then seeds complexes with
proteins, considered by their decreasing weights, and include only vertices of weights
above a given threshold, at each time. The clustering based on maximal cliques
(CMC) method (Liu, Wong, & Chua, 2009) starts by using an iterative scoring
scheme to assign weights to protein interactions. Lower scores correspond to less
reliable interactions in order to reduce their impact in the detection process. All
maximal cliques are generated from the PPI network and then, they are ranked based
on their weighted density. Finally, highly overlapping cliques are merged or
removed. The Affinity Propagation (AP) algorithm (Frey & Dueck, 2007) uses a
distance matrix to propagate messages between nodes until a high-quality set of
“exemplars” and corresponding clusters are gradually generated. ClusterONE
(Nepusz, Yu, & Paccanaro, 2012) identifies protein complexes through clustering
with overlapping neighborhood expansion. A cohesiveness measure is introduced to
reflect the notion by which a protein complex is viewed as an entity that is wellseparated from the rest of the network and whose members have reliable
interconnections. Proteins are considered by their descending order of degrees and a
greedy algorithm is applied to generate complexes by joining proteins which are not
yet added to any complex. Next, groupings with high overlaps are merged and
complexes with less than three proteins or with low density are discarded. The
Restricted Neighborhood Search Clustering (RNSC) algorithm, presented in (King,
Pržulj, & Jurisica, 2004) and (Pržulj, Wigle, & Jurisica, 2004), is a cost-based local
search algorithm that uses the tabu metaheuristic. It seeks to partition proteins into
highly-interconnected subsets. The method starts with a random clustering and then,
moves nodes from one group to another to improve clustering cost. The RRW
algorithm (Macropol, Can, & Singh, 2009) exploits the global structure of a PPI
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network using repeated random walks. It moves from one node to another based on
the probabilities of the connective edges. CFinder (Adamcsek et al., 2006) finds
overlapping and fully-connected complexes based on the clique percolation method.
The GIBA tool (Moschopoulos, Pavlopoulos, Schneider, Likothanassis, & Kossida,
2009) clusters the whole network and then, filters the generated clusters in order to
only keep the important ones.
Although these state-of-the-art methods offer good solutions to the
considered problem, most of them are bound by the assumption that protein
complexes only correspond to dense subgraphs in protein interaction networks. As a
result, they cannot identify complexes with few members and/or few interactions.
That is an important drawback to overcome since for instance, among the 313 protein
complexes included in the MIPS catalogue (Mewes et al., 2006), 104 complexes
consist of 2 or 3 proteins (approximately 33%). ProRank, introduced in (Zaki,
Berengueres, & Efimov, 2012a) and (Zaki, Berengueres, & Efimov, 2012b) is a
recent complex-detection method which is not restrained by this density supposition.
It is mainly based on a protein ranking algorithm inspired by Google’s PageRank
algorithm discussed in (Brin & Page, 1998), (Bryan & Leise, 2006), (Ishii & Tempo,
2010) and (Langville & Meyer, 2011). As PageRank sorts web pages according to
their level of importance, ProRank applies the same analogy to rank proteins in PPI
networks, and subsequently, to identify the “essential” ones which most-likely have
central roles in cellular functions. Those proteins are the starting point based on
which the detected complexes are formed. In addition, the pairwise similarities of the
proteins are computed under the assumption that proteins belonging to the same
complex share evolutionary relationships (Kuang, Weston, Noble, & Leslie, 2005).
In view of the notable performance of ProRank when compared to previous
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approaches, the algorithm is the keystone of our approach introduced hereafter. Five
main steps delineate the ProRank algorithm (Zaki, Berengueres, & Efimov, 2012a):
1- Pruning: PPI datasets are usually noisy; they have high false-positive and
false-negative rates (Reguly et al., 2006). Accordingly, the first step
consists of removing unreliable interactions which could negatively affect
the detection process. That is done using the AdjustCD method introduced
in (Chua, Sung, & Wong, 2006) and (Chua, Ning, Sung, Leong, & Wong,
2008); a weighting scheme that iteratively calculates the reliability of
protein interactions based on the topology of the network and then discards
the interactions with scores less than a specified threshold.
2- Filtering: based on the protein interaction network, three types of noisy
proteins are identified: bridge proteins which have a disconnected
subgraph of neighbors; fjord proteins whose neighbors have a small
number of interactions among each other; and shore proteins which have at
least one neighbor with significantly few interactions with other proteins.
Accordingly, the network vertices are examined for possible memberships
in these types. Figure 5 illustrates examples of the three described
categories.

fjord
protein

bridge
protein
shore

Figure 5: Examples of bridge, fjord and shore proteins in PPI networks.
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3- Protein Similarity Calculating: proteins belonging to the same complex are
expected to have evolutionary relationships (Kuang, Weston, Noble, &
Leslie, 2005). Therefore, the similarity scores among all the proteins in the
PPI network are calculated using pairwise alignment.
4- Protein Ranking: in analogy with the PageRank algorithm, a ranking
algorithm is applied to order the proteins by their importance in the
interaction network.
Given 𝑛 interacting proteins, we represent their interaction network by a
graph 𝐺 = (𝑉, 𝐸) where 𝑉 = 1, 2, … , 𝑛 is the set of nodes (proteins) and E
the set of edges (interactions) among those proteins and (𝑖, 𝑗) ∈ 𝐸 if
protein 𝑖 interacts with protein 𝑗. The goal of the ranking algorithm is to
order proteins by their importance in the network. Accordingly, the
importance measure 𝑥𝑖 of protein 𝑖 is a real number such that 𝑥𝑖 ∈ [0,1]
and 𝑥𝑖 > 𝑥𝑗 means that protein 𝑖 is more important than protein 𝑗. The
value of a protein is given by the sum of contributions of all proteins
interacting with it. The importance of protein 𝑖 is based on the following
equation:
∗
𝑥𝑖 = ∑ 𝑆𝑖,𝑗
. 𝑛𝑗

(1)

𝑗∈𝜏𝑖

where 𝜏𝑖 ≔ {𝑗: (𝑗, 𝑖)𝜖𝐸} is the index set of the proteins interacting with 𝑖,
𝑛𝑗 is the number of outgoing links from node 𝑗 and 𝑆 ∗ is the normalized
similarity matrix computed in the Protein Similarity Calculating step. The
total of all values is normalized i.e. ∑𝑛𝑖=1 𝑥𝑖 = 1. Let the values of 𝑥 be in
the vector form where 𝑥 ∈ [1,0]𝑛 . The PageRank algorithm can thus be
rewritten as:
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𝑥 = 𝑆 ∗ 𝑥, 𝑥 ∈ [1,0]𝑛 and ∑𝑛𝑖=1 𝑥𝑖 = 1

(2)

Note that the vector x is a nonnegative eigenvector corresponding to the
eigenvalue 1 of the nonnegative matrix 𝑆 ∗ . Nonetheless, for this
eigenvector to exist and to be unique, it is essential that the PPI network is
strongly connected. To find the eigenvector corresponding to the
eigenvalue 1, a modified version of the values is defined as follows. Let 𝑚
be a parameter such that𝑚 ∈ (0,1), and let the modified interaction matrix
𝑀 ∈ ℜ𝑛×𝑛 be given by:
𝑀 ≔ (1 − 𝑚)𝑆 ∗ +

𝑚
𝑙
𝑛

(3)

where 𝑙 is an 𝑛 × 𝑛 matrix with all entries equal to 1. A typical value of 𝑚
is 0.15. 𝑀 is a positive stochastic matrix. Thus, according to Perron
theorem 33, this matrix is primitive. Particularly, |𝜆| = 1is the unique
maximum eigenvalue. Therefore, we apply the following formula to find
corresponding eigenvector 𝑥:
𝑥(𝑘 + 1) = 𝑀𝑥(𝑘) = (1 − 𝑚)𝑆 ∗ 𝑥(𝑘) +

𝑚
𝑙
𝑛

(4)

where 𝑥(𝑘) ∈ ℜ𝑛×1 and the initial vector 𝑥(0) ∈ ℜ𝑛×1 is a probability
vector. Expanding on the convergence rate of this scheme, let 𝜆1 (𝑀) and
𝜆2 (𝑀) be the largest and the second largest eigenvalues of 𝑀 in
magnitude. Then, by the power method applied to 𝑀, the asymptotic rate
of

convergence

is

exponential

and

depends

on

the

ratio

|𝜆2 (𝑀)⁄𝜆1 (𝑀)|.Since 𝑀 is a positive stochastic matrix, we have 𝜆1 (𝑀) =
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1 and 𝜆2 (𝑀) < 1. Therefore, the structure of the link matrix 𝑀 leads us to
the bound:
|𝜆2 (𝑀)| ≤ 1 − 𝑚

(5)

5- Complex Detection: the essential proteins are the ones which do not
belong to any of the categories defined in step 2. Using the spoke model,
those proteins are considered by their decreasing ranking order and each of
them is pulled from the interaction network along with its neighbors to
form a protein complex. Note that each protein can belong to one complex
only.
In addition to those five steps, ProRank discards complexes of less than three
members and merges two complexes if more than 50% of the neighbors of each
protein belonging to the first complex are in the second complex. Figure 6 shows the
workflow of the ProRank algorithm.
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Protein-Protein
Interaction Network
Pruning
Removing unreliable interactions

Filtering
Identifying bridge, fjord and shore
proteins
Protein Similarity Calculating
Calculating the similarity scores
among all proteins
Protein Ranking
Ordering proteins by their importance
in the interaction network

Complex Detection
Forming complexes based on essential
proteins and using the spoke model

Post-Processing
Discarding small complexes and
merging highly-overlapping ones

Set of Detected
Protein Complexes

Figure 6: The workflow of the ProRank algorithm which
takes as input a protein-protein interaction network and
detects the corresponding protein complexes.

Figure 109: Yeast PPI sub-network. The nodes colored in yellow
correspond to essential proteins identified by the ProRank
algorithm.Figure 110: The workflow of the ProRank

algorithm which takes as input a protein-protein interaction
network and detects the corresponding protein complexes.
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2.2 Detecting Protein Complexes in Dynamic Protein-Protein Interaction
Networks
PPI networks are dynamic in nature (Levy & Pereira-Leal, 2008). In the
direction of acquiring better complex-detection results, computational methods ought
to profit from the abundance of biological information provided by advanced
experimental techniques to model the dynamics of protein interactions. A single
network is usually used to represent a PPI dataset. In contrast, a dynamic PPI
network can be visualized by a series of schemes representing snapshots of the
network states, corresponding to different stages and/or locations of molecular
activities. We will hereafter highlight some of the potential concepts and approaches
that can be used to model the dynamics of protein interaction networks.
Gene expression datasets present quantitative measurements of RNA species
in cellular compartments across different conditions (Lovén et al., 2012). Genomewide expression levels can now be generated (Secrier & Schneider, 2013). Timeseries gene expression data report quantities of RNA species across various time
points in cellular processes. Genes with correlated expressions across subsets of
conditions most likely interact. When combined with PPI data to simulate the
interaction dynamics, they can potentially reveal the processes which underline the
formation of protein complexes. We note here that not all the genes described in one
biological dataset may be covered in another dataset. However, combining data from
multiple sources is viewed as advantageous since it helps overcome data limitations
such as false-positive and false-negative interactions in PPI datasets and low gene
coverage in gene expression datasets. For example, PPI and gene expression data
combination is done in (Wang, Peng, Xiao, Li, & Pan, 2013) where it is shown that a
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just-in-time mechanism elapsing through continuous time points delineates the
formation of most protein complexes. The statistical 3-sigma principle is used in
(Wang, Peng, Xiao, Li, & Pan, 2013) and (Wang, Peng, Li, Luo, & Pan, 2011) to
define the active time points of proteins based on their gene expression levels and
thus, to introduce approaches for the identification and refinement of protein
complexes. The core-attachment composition of complexes is recently considered in
(Li, Chen, Wang, Wu, & Pan, 2014). Relying on gene expression data, the
identification of a protein complex is split into two main parts: a static core
consisting of proteins expressed throughout the whole cell cycle and short-lived
proteins that form a dynamic attachment. The results of these approaches are better
than the ones deduced from static networks. Kim et al. (Kim, Han, Choi, & Hwang,
2014) highlight some of the computational methods used to infer dynamic networks
from expression data, based on statistical dependence to categorize nodes and/or
edges as active or not. These methods include: Bayesian networks (Friedman, Linial,
Nachman, & Pe'er, 2000), relevance networks (Remondini et al., 2005), Markov
Random Fields (Song, Kolar, & Xing, 2009), ordinary differential equations (Bansal,
Belcastro, Ambesi‐Impiombato, & Di Bernardo, 2007) and logic-based models
(Morris, Saez-Rodriguez, Sorger, & Lauffenburger, 2010).
As it is conditioned by time, the occurrence of a protein interaction is also
subject to the co-localization of its interacting partners in cellular components (Park
et al., 2011). In fact, unsuccessful interactions caused by inappropriate protein
localizations can be pathological. Consequently, subcellular localization annotations
(de Lichtenberg, Jensen, Brunak, & Bork, 2005) can be also used to model dynamic
PPI networks based on spatial constraints. Indeed, the formation of protein
complexes is influenced by the localization settings of proteins as well. As a result, it
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is certainly beneficial to incorporate the spatial dynamics in the direction of
improving complex-detection approaches. Various methods aim at studying and
collecting spatial movements of proteins (Lee, Tan, & Chung, 2010). However, in
addition to mathematical modeling techniques, methods to appropriately integrate
spatial protein dynamics in PPI networks are still required.
Gene ontology annotations (Ashburner et al., 2000) provide information
about genes across different species. They can potentially infer the dynamic aspect of
PPI networks (Xu, Lin, & Yang, 2010). As an indicator of interaction probability,
various weighting schemes are introduced to assign PPI weights based on the
similarity degrees of gene ontology terms between interacting partners. Among these
approaches are: SWEMODE (Lubovac, Gamalielsson, & Olsson, 2006), which
detects communities within PPI networks based on weighted clustering coefficient
and weighted average nearest-neighbors degree measures; and OIIP (Xu, Lin, &
Yang, 2010), which identifies protein complexes in PPI networks by assigning node
and edge weights based on the size of gene annotations.
By modeling the dynamics of PPI networks, we can potentially: reproduce
the mechanisms of protein-complex formation; uncover new biological facts about
complexes; overcome limitations existing in most experimental datasets; categorize
modules deduced from PPI networks; and finally, increase the accuracy and
reliability of the detected results.
2.3 Associating Genes to Diseases
The identification of the genes and the inter-molecular events leading to the
formation of diseases remains an essential research area towards the development of
effective medical treatments. Based on the assumption that genes related to similar
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disorders tend to be functionally associated (Oti & Brunner, 2007) (Wu, Jiang,
Zhang, & Li, 2008), existing methods often follow a guilt-by-association (Altshuler,
Daly, & Kruglyak, 2000) conjecture by which genes are ranked by their similarity to
known disease genes. We hereafter list various existing approached for gene-disease
association.
Deng et al. (Deng, Chen, & Sun, 2004) combine physical and genetic
interactions of proteins with gene expression networks, protein complex data and
domain structures to form an integrated probabilistic model to predict protein
functions. They apply the Markovian random field theory. Xu and Li (Xu & Li,
2006) classify genes as disease-related or not based on PPI network topology
features, using the k-nearest neighbor algorithm. Ma et al. (Ma, Lee, Wang, & Sun,
2007) apply a method based on Markov Random Field (MRF) on a high-throughput
dataset comprising gene expression profiles and protein interaction data. They seek
to prioritize disease genes without requiring known candidate genes. Lage et al.
(Lage et al., 2007) consider that mutations in members of protein complexes lead to
comparable phenotypes. Accordingly, they build a phenome-interactome network by
integrating phenotypic data and phenotypic similarities with a high-confidence
human protein interaction network. They use a Bayesian classifier to potentially link
previously-unknown protein complexes to diseases. Köhler et al. (Köhler, Bauer,
Horn, & Robinson, 2008) apply a random walk with restart algorithm (RWR) on a
heterogeneous interaction network to prioritize candidate disease genes. They
consider that global network-similarity measures reflect the relationships among
disease genes better than direct or shortest-paths algorithms. Li and Agarwal (Li &
Agarwal, 2009) use pathway data to answer the gene prioritization problem. They
examine disease relationships via literature mining to identify disease genes. That is
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done by associating diseases to biological pathways where those genes are enriched
and linked to diseases based on their shared pathways. Zhang et al. (Zhang et al.,
2012) construct a combined classifier on multiple PPI network topology features to
identify disease genes. Guan et al. (Guan et al., 2012) create tissue-specific
functional networks to prioritize disease genes. Their approach is based on the notion
by which tissue-specificity is viewed as an essential factor that highlights the
diversity of protein roles in different cell lineages. In other words, forming tissuespecific functional networks can potentially lead to more accurate gene-phenotype
associations. Li et al. (Li et al., 2014) introduce novel topological attributes and use
support vector machines (SVM) to classify genes as disease-related or not. Chen et
al. (Chen B. , Wang, Li, & Wu, 2014) introduce a method based on the Markovian
random field theory and Bayesian analysis for gene-disease association. They
combine biological data from multiple sources in order to prioritize disease genes.
Although most of the existing approaches perform well, their limitations
mainly reside in requiring initial settings of parameters and thresholds in addition to
the dependence on a single set of gene features, either topological or biological.
2.4 Summary
The literature offers various solutions to the research problem and objectives
that we address in our work. Nevertheless, the research area remains open thanks to
the continuously-growing biological knowledge provided by advanced experimental
techniques. In view of that, we seek to overcome the limitations of the existing
approaches while developing algorithms that are also enriched by the available
biological information. Accordingly, the proposed solution for the first objective is
not bound by the assumption that protein complexes only correspond to dense
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subgraphs in PPI networks. Complexes may also overlap. In addition, postprocessing steps are introduced to examine and refine the detected entities based on
their overlapping protein members. In the second objective, we model the dynamic
aspect of protein interaction networks by incorporating time-series gene expression
data. The expressions are analyzed using biclustering techniques (Busygin,
Prokopyev, & Pardalos, 2008) which allow the identification of subsets of coregulated genes across subsets of samples. And in analogy to biological facts, by
using these techniques, a gene can belong to multiple clusters or may not fit in any
cluster as well. Finally, we present a classification model for the gene-disease
association problem which is built based on integrated PPI network topology
attributes and various biological features collected from multiple sources. We believe
that by combining computationally-conveyed network analysis and experimentallygenerated biological information, the gene-disease association process can be greatly
enhanced.
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Chapter 3: Detecting Protein Complexes in Protein-Protein Interaction
Networks
In this chapter, we present our approach for the detection of protein
complexes in PPI networks. Section 3.1 revisits some background information of the
research objective. In section 3.2, our ProRank+ method is introduced. The
performance of ProRank+ is tested and compared to the performance of existing
state-of-the-art approaches in section 3.3. The chapter conclusion is in section 3.4.
3.1 Background
The importance of this objective originates from the fact that protein
complexes are key players in most cellular processes (Gavin et al., 2006). Designing
suitable methods for the detection of protein complexes in protein interaction
networks continues to be an intriguing area of research. The more complexes we
identify, the better we can perceive normal as well as abnormal molecular events.
Given a set of proteins that participate in a process under study and based on the
interconnections that they exhibit, biologists use advanced experimental techniques
to identify the corresponding protein complexes. Nevertheless, this procedure is
often accompanied with extensive time and cost requirements. Computational
approaches are consequently developed in order to overcome those drawbacks. Their
goal is to narrow down the required experimental work by pinpointing protein groups
which presumably correspond to complexes. Among the existing methods, we here
recall: the Markov Clustering Algorithm (MCL) (Van Dongen, 2001) which uses
random walks to find cluster structures in PPI networks; the Molecular Complex
Detection (MCODE) algorithm (Bader & Hogue, 2003) which interprets complexes
as dense regions grown from highly-weighted vertices; the clustering based on
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maximal cliques (CMC) method (Liu, Wong, & Chua, 2009); the Affinity
Propagation (AP) algorithm (Frey & Dueck, 2007) that uses a distance matrix to
gradually generate high-quality clusters; the Restricted Neighborhood Search
Clustering (RNSC) algorithm, presented in (King, Pržulj, & Jurisica, 2004) and
(Pržulj, Wigle, & Jurisica, 2004), which is a cost-based local search algorithm that
seeks to partition proteins into highly-interconnected subsets; the RRW algorithm
(Macropol, Can, & Singh, 2009) that uses repeated random walks to exploit the
structure of PPI networks; CFinder (Adamcsek et al., 2006) which looks for
overlapping and fully-connected complexes based on the clique percolation method;
and recently, ClusterONE (Nepusz, Yu, & Paccanaro, 2012) which identifies protein
complexes through clustering with overlapping neighborhood expansion. Despite the
good performance of these methods, most of them are restricted by the assumption
that protein complexes only correspond to dense subgraphs in PPI networks. Thus,
they are usually unable to detect complexes with few members and/or few
interconnections.

Our approach for the detection of protein complexes in PPI

networks is based on the ProRank method (Zaki, Berengueres, & Efimov, 2012a),
presented in Chapter 2, which is not restrained by the complex-density assumption.
We consider the network presented in Figure 7 to trace the ProRank algorithm. It is a
sub-network generated from the yeast PPI dataset at the Mentha interactome browser
(Calderone, Castagnoli, & Cesareni, 2013), version date 05/01/2014. It corresponds
to the largest connected portion of the network and includes 235 interactions of
scores greater than or equal to 0.99. The yellow nodes correspond to the essential
proteins identified by ProRank and the detected protein complexes are presented in
Figure 7.
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Figure 7: Yeast PPI sub-network. The nodes colored in yellow correspond
to essential proteins identified by the ProRank algorithm.

Figure 8: Detected complexes by the ProRank algorithm when
applied on the PPI network in Figure 7, under the assumption that
a protein can belong to one complex only.
3.2 The ProRank+ Method
Granting that ProRank achieves competitive results when compared to
previous approaches, it can be further improved. The pruning, filtering, ranking and
complex-detection steps are certainly requisite. In fact, PPI datasets are usually
noisy. They have high false-positives (spuriously-detected interactions) and falsenegatives (missing interactions) rates which could negatively affect the detection
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process. Accordingly, it is important to remove the unreliable edges or even detect
the missing ones using proper computational techniques. Categorizing the proteins
and forming the detected complexes based on the essential nodes can potentially lead
to more accurate results. Moreover, ranking the proteins by their importance in the
network and using the spoke model to form protein complexes are all vital to the
complex-detection algorithm. Nevertheless, the similarity calculating step can be
discarded due to its high computational cost and its low effect on the final results
(Zaki, Berengueres, & Efimov, 2012a).
Proteins can participate in multiple cellular functions (Hodgkin, 1998).
Hence, a protein can belong to many complexes. For instance, among the 1189
proteins contained in the MIPS catalog of protein complexes (Mewes et al., 2006),
820 proteins (approximately 69%) belong to more than one complex. Similarly,
among the 1279 complexes covered by the SGD set (Hong et al., 2008), 332 proteins
(approximately 26%) belong to multiple complexes. Consequently, the detected
protein complexes are expected to have common members. A detection algorithm
which accounts for this fact would most likely lead to more accurate results. This is
the first alteration of ProRank. To do that, we explore the formation of protein
complexes from various protein seeds by allowing the complexes to overlap. Indeed,
the number of detected entities would increase but it is then subject to merging or
deleting entities based on their degrees of overlaps. The complexes detected after
adding the overlap assumption to ProRank and applying it on the PPI network in
Figure 7, are shown in Figure 9.
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Figure 9: Detected complexes by the ProRank algorithm when applied on the
PPI network in Figure 7, under the assumption that a protein may belong to
more than one complex.
The results uphold the improvement added by allowing the detected
complexes to overlap. However, it can be noticed that the amount of overlaps among
some of the detected complexes is relatively high. This was anticipated. Actually,
since all essential proteins are now seeds for protein-complex formation, the ones
that share numerous neighbors will certainly produce highly similar protein
complexes. In order to overcome this limitation and to further improve the quality of
the predicted complexes, the following filtering and merging steps are added to the
algorithm:
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1- Duplicate complexes resulting from the complex-overlap notion are
removed.
2- Next, a merging procedure, Merging by Cohesiveness, is applied to
explore more variations of the detected complexes. In conformity with the
initial considerations of the ProRank method, we rely on the key roles of
the essential proteins in the network to establish the merging process. All
the detected complexes are matched against each other. Two complexes,
C1 and C2, whose percentage of overlapping essential proteins is above a
merging threshold, are merged along with their interconnections to form a
larger complex C. Then, the process uses the cohesiveness measure
introduced in (Nepusz, Yu, & Paccanaro, 2012) to assess the quality of the
resulting complex and its iterative extensions as follows. The cohesiveness
of a complex C is given by equation (6):
𝐶𝑜ℎ𝑒𝑠𝑖𝑣𝑒𝑛𝑒𝑠𝑠(𝐶) =

𝑤𝑖𝑛 (𝐶)
𝑤𝑖𝑛 (𝐶) + 𝑤𝑜𝑢𝑡 (𝐶) + 𝑝

(6)

where win(C) is the sum of the weights of edges that are entirely contained
in C, wout(C) is the sum of the weights of edges that connect the proteins
belonging to C to the rest of the network and p is a penalty term reflecting
PPI uncertainties. This cohesiveness measure was developed to model the
assumption by which a protein complex is viewed as an entity with
strongly-interconnected members that is well-separated from the rest of the
network. The successive steps of our merging procedure aim at refining
merged complex while increasing their cohesiveness measures. For each
protein, prot, contained in C: first, the set of its neighbors, Nprot, is formed;
then, for each neighbor protein nprot in Nprot, the complex C’=C ∪ {nprot} is
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constructed; and if the cohesiveness of C’ is greater or equal to the
cohesiveness of C, nprot is added to C. After exploring all the proteins
initially belonging to C in the same manner, the derived complex is added
to the final list of detected complexes. The pseudocode of merging two
complexes, Merge_by_Cohesiveness, is presented next.
Pseudocode of the Merge-by-Cohesiveness algorithm
Merge_by_Cohesiveness (C1, C2, merging_threshold)
ep1 = (set of essential proteins in C1)
ep2 = (set of essential proteins in C2)
if size(ep1) > size(ep2) then
larger_set = ep1
else larger_set = ep2
end if
ep = ep1 ∪ ep2
if size(ep) > size(larger_set)*merging_threshold then
C = C1 ∪ C2
for prot in C do
N_prot = (set of neighbors of prot)
for n_prot in N_prot do
C’ = C ∪ {n_prot}
if Cohesive(C’) ≥ Cohesive(C) then
C = C ∪ {n_prot}
end if
end for
end for
end if

3- Additional screening of the generated complexes is applied to remove
possible duplicates.
In summary, Figure 10 shows the steps of the ProRank+ algorithm.
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Figure 10: Steps of the ProRank+ algorithm.
3.3 Experimental Study
3.3.1 Datasets and Evaluation Criteria
ProRank+ is tested on five large-scale protein-protein interaction datasets
associated to the well-studied yeast microorganism. Four of the datasets consist of
weighted protein interactions, they are: Collins (Collins et al., 2007), Krogan core
and Krogan extended (Krogan et al., 2006), and Gavin (Gavin et al., 2006). The fifth
dataset, BioGRID (Stark et al., 2006), consists of unweighted interactions. The
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characteristics of the five datasets used in the experimental work are shown in Table
1.
No. of
No. of
Network Average no.
Proteins Interactions Density of neighbors
1,622
9,074
0.007
11.189
Collins
2,708
7,123
0.002
5.261
Krogan Core
14,317
0.002
7.798
Krogan extended 3,672
1,855
7,669
0.004
8.268
Gavin
5,640
59,748
0.004
21.187
BioGRID
Dataset

Table 1: Characteristics of the five experimental datasets.
The sets of predicted complexes are matched against the MIPS catalog of
Figure 246: ProRank+ compared to ProRank, MCL,
protein complexes
(Mewes
et al.,
The same RNSC,
datasets and
the reference
set of
MCODE,
CMC,
AP,2000).
ClusterONE,
RRW,
and
the fourthe
weighted
yeast datasets
complexes CFinder.
are used Here,
to evaluate
ClusterONE
method are
and used:
to compare its
Collins, Krogan core, Krogan extended and Gavin. The
are in terms
(a) adopt
the number
of quality
clustersscores
that applied in
performancecomparisons
with other approaches.
Weofalso
the same
match the reference complexes, (b) the geometric accuracy
(Nepusz, Yu,
& Paccanaro,
2012)the
to clustering-wise
assess the quality
of our algorithm.
(Acc)
which reflects
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(Sn) and In addition,
the clustering-wise positive predictive value (PPV), and (c)
it is important to note that the parameters of the compared algorithms are optimized
the maximum matching ratio (MMR).Table 38:
Characteristics
of the
five experimental
datasets.
in such a way
to produce best
possible
results. Given
m predicted complexes and n
reference complexes and based on the confusion matrix, T = [tij], the quality scores
cover:

Figure 247: ProRank+ compared to ProRank, MCL,
MCODE, CMC, AP, ClusterONE, RNSC, RRW, and
Here,ofthe
four weighted
datasets
are that
used:are matched
a. CFinder.
The number
complexes
in the yeast
reference
catalog
Collins, Krogan core, Krogan extended and Gavin. The
comparisons
of (a) thecomplexes
number ofwith
clusters
that score, w,
with at leastare
oneinofterms
the predicted
an overlap
match the reference complexes, (b) the geometric accuracy
greater
thanreflects
0.25. The
overlap score of
two complexes
(Acc)
which
the clustering-wise
sensitivity
(Sn) and A and B is
the clustering-wise positive predictive value (PPV), and (c)
calculated based on equation (7).
the maximum matching ratio (MMR).
|𝐴 ∩ 𝐵|2
(7)
𝑤(𝐴, 𝐵) =
|𝐴||𝐵|
Figure 248: ProRank+ compared to ProRank, MCL,
b. MCODE,
The clustering-wise
sensitivity
(Sn) and
which
assesses
quality
AP, ClusterONE,
RNSC,
RRW.
Here,the
thematching
unweighted BioGRID dataset is used. The comparisons are in
among the reference complexes and the detected ones. It is calculated
terms of (a) the number of clusters that match reference
complexes,
(b) the
as shown inand
equation
(8). geometric accuracy (Acc) which
reflects the clustering-wise sensitivity (Sn) and the clusteringwise positive predictive value (PPV), and the maximum
matching ratio (MMR).Figure 249: ProRank+ compared to
ProRank, MCL, MCODE, CMC, AP, ClusterONE, RNSC,
RRW, and CFinder. Here, the four weighted yeast datasets
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𝑚
∑𝑛𝑖=1 𝑚𝑎𝑥𝑗=1
𝑡𝑖𝑗
𝑆𝑛 =
𝑛
∑𝑖=1 𝑛𝑖

(8)

c. The clustering-wise positive predictive value (PPV) which also reflects
the matching quality, mainly in terms of the correctly-matched protein
members among the detected complexes. It is computed as shown in
equation (9).
𝑃𝑃𝑉 =

𝑛
∑𝑚
𝑗=1 𝑚𝑎𝑥𝑖=1 𝑡𝑖𝑗
𝑛
∑𝑚
𝑗=1 ∑𝑖=1 𝑡𝑖𝑗

(9)

d. The geometric accuracy (Acc) which is the geometric mean of Sn and
PPV, as shown in equation (10).
𝐴𝑐𝑐 = √𝑆𝑛 × 𝑃𝑃𝑉

(10)

e. The maximum matching ratio (MMR) which reflects how accurately the
predicted complexes represent the reference complexes by dividing the
total weight of the maximum matching by the number of reference
complexes.
3.3.2 Experimental Settings of ProRank+
The steps of applying ProRank+ on a given dataset, D, and their experimental
settings are as follows:
1- Pruning: removing unreliable protein interactions from D using the
AdjustCD method (Chua et al., 2008). This technique assigns weights to
the interactions based on the network topology and considers unreliable
those whose weights are less than a specified threshold. Here, we
experimentally set the pruning threshold to 0.2 for weighted datasets and
to 0.45 for unweighted datasets.
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2- Filtering: identifying bridge, fjord, and shore proteins which could add
noise to the network, as defined in (Zaki, Berengueres, & Efimov, 2012a).
3- Protein Ranking: ordering proteins using a ranking algorithm, in analogy
with the PageRank algorithm.
4- Complex Detection: considering all the essential proteins, i.e. those that do
not belong to any of the types defined in step 2, as seeds based on which
detected complexes are formed using the spoke model. Here, a protein can
belong to more than one complex.
5- Pre-processing: filtering the set of predicted complexes by removing
possible duplicates generated due to the introduced overlap assumption.
6- Merging by Cohesiveness: two detected complexes, whose overlap is
above a merging threshold, here 75%, are merged. The subsequent
complex is iteratively extended following the presented merging
procedure.
7- Post-processing: filtering the refined set of predicted complexes to remove
possibly replicated copies of the same complexes resulting from the
previous merging step.
3.3.3 Comparison with Other Methods
ProRank+ is compared to other state-of-the-art methods. They include
ProRank (Zaki, Berengueres, & Efimov, 2012a) to highlight the attained
improvement, Markov Clustering (MCL) (Van Dongen, 2001), the molecular
complex detection (MCODE) algorithm (Bader & Hogue, 2003), the clustering based
on maximal cliques (CMC) method (Liu, Wong, & Chua, 2009), the Affinity
Propagation (AP) algorithm (Frey & Dueck, 2007), ClusterONE (Nepusz, Yu, &
Paccanaro, 2012), the restricted neighborhood search (RNSC) algorithm (King,
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Figure 11: ProRank+ compared to ProRank, MCL, MCODE, CMC, AP,
ClusterONE, RNSC, RRW, and CFinder. Here, the four weighted yeast
datasets are used: Collins, Krogan core, Krogan extended and Gavin. The
comparisons are in terms of (a) the number of clusters that match the
reference complexes, (b) the geometric accuracy (Acc) which reflects the
clustering-wise sensitivity (Sn) and the clustering-wise positive predictive
value (PPV), and (c) the maximum matching ratio (MMR).
Pržulj, & Jurisica, 2004), the RRW algorithm (Macropol, Can, & Singh, 2009), and
CFinder (Adamcsek, Palla, Farkas, Derényi, & Vicsek, 2006). The comparisons
among the results scored by these approaches (Nepusz, Yu, & Paccanaro, 2012) and
those scored by ProRank + are displayed in Figures 11 and 12. Since not all the
algorithms can be applied to unweighted datasets, fewer methods for instance were
applied on the BioGRID dataset.
The experimental results show that ProRank+ detects a higher number of
protein complexes that are matched with the reference set. Note that the number of
clusters predicted by ProRank+ is relatively higher than the number of clusters
returned by the other methods for Collins, Gavin and BioGRID datasets.
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Figure 12: ProRank+ compared to ProRank, MCL, MCODE, AP,
ClusterONE, RNSC, and RRW. Here, the un-weighted BioGRID
dataset is used. The comparisons are in terms of (a) the number of
clusters that match reference complexes, and (b) the geometric
accuracy (Acc) which reflects the clustering-wise sensitivity (Sn)
and the clustering-wise positive predictive value (PPV), and the
maximum matching ratio (MMR).
Nevertheless, the ratio equivalent to the number of matched complexes over the
number of detected clusters falls within the same range of the ratio corresponding to
the other methods. Added to that, ProRank+ achieves higher clustering-wise
sensitivity (Sn), geometric accuracy (Acc) and maximum matching ratio (MMR) for
all the considered datasets. However, it cannot surpass the clustering-wise positive
predictive value (PPV) of ProRank which was the highest for all datasets. This can
be justified by the fact that PPV tends to be lower when the overlaps among the
detected complexes are substantial. By the PPV formula, a complex-detection
algorithm that fully succeeds in detecting the reference complexes has a PPV value
less than or equals to 1 since there is a matching predicted complex for every
reference complex, in addition to other predicted complexes that partially overlap
with reference complexes. On the other hand, a dummy detection algorithm which
distributes the proteins into separate sets of single elements has a PPV value equals
to 1, which is greater than the PPV of the perfect algorithm that is able to detect all
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reference complexes. Consequently, PPV values must be carefully analyzed since
they may not always reflect the competence of a certain method. Moreover, the
geometric accuracy (Acc) is negatively affected by the predicted complexes that do
not match any of the reference complexes. This somehow contradicts the initial
purpose of developing methods for the detection of protein complexes which mainly
consists of finding previously unknown or undiscovered entities. Accordingly, the
MMR measure (Nepusz, Yu, & Paccanaro, 2012) is introduced to overcome such
limitations by dividing the total weight of the maximum matching with the number
of reference complexes. The MMR values achieved by ProRank+ are in the favor of
the proposed approach. We hereby note that our approach can also be explored using
other pruning methods such as the ones introduced in (Zaki, Efimov, & Berengueres,
2013) and (Kritikos, Moschopoulos, Vazirgiannis, & Kossida, 2011).
3.3.4 Testing the Ability of ProRank+ to Detect Small Complexes
Detecting small protein complexes is not a common feature of complexdetection methods. In fact, it is important to identify such complexes in protein
interaction networks. For instance, among the 313 protein complexes included in the
MIPS catalogue (Mewes et al., 2006), 104 complexes consist of 2 or 3 proteins
(approximately 33 %). Most of the approaches which view protein complexes as
dense regions in the interaction networks are usually unable to detect complexes of
small sizes. Hence, we also test the ability of ProRank+ to detect small protein
complexes. We consider the same yeast datasets that are utilized in the previous
experiments. The set consisting of the 104 complexes of small sizes in the MIPS
catalogue (Mewes et al., 2006) is formed and used as a reference set. The datasets are
filtered by the AdjustCD method with a threshold of 0.2. The corresponding results
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are shown in Table 2. The table highlights the competency of ProRank+ in detecting
small protein complexes in terms of the number of matched complexes as well as the
accuracy (Acc) and the maximum matching ratio (MMR) scores.
Dataset
Collins
Krogan Core
Krogan Extended
Gavin
BioGRID

Predicted
Complexes

Matched
Complexes

Sn

428
229
260
534
823

91
34
78
57
78

0.875
0.667
0.75
0.897
0.882

Acc MMR
0.935
0.816
0.769
0.947
0.9

0.433
0.163
0.217
0.293
0.351

Table 2: The results of testing ProRank+ on small complexes.
3.3.5 Testing ProRank+ on Human Protein-Protein Interaction Dataset
Table 150: Selected complexes detected by ProRank+ when tested
on human
protein-protein
interaction
151:
The is able
When
tested on
various datasets,
weighted dataset.Table
and unweighted,
ProRank+
results of testing ProRank+ on small complexes.
to detect more complexes than state-of-the-art methods with higher quality scores.
Indeed, the method could be very helpful for biologists if it is also tested on Human
Table 152: Selected complexes detected by ProRank+ when tested
on human
protein-protein
interactions
and proved
valuable ininteraction
detecting dataset.
known protein complexes of key roles
in normal and abnormal cellular functions. Therefore, we apply our method on the
Figure 373:
Snapshots
of a in
hypothetical
PPI repository
network, showing
Human protein
interactions
dataset
the BioGRID
(Stark etitsal., 2006).
dynamics through different temporal, spatial and/or contextual
settings.are
Nodes
and edges
the the
same
color threshold
belong towas
the set
same
The interactions
unweighted,
andofthus
pruning
to 0.45. The
protein complex.Table 153: Selected complexes detected by
pruned dataset
consists
of 3031
is able tointeraction
predict 267 protein
ProRank+
when
testedinteractions.
on humanProRank+
protein-protein
dataset.Table 154: The results of testing ProRank+ on small
complexes. We then examine the detected entities for potential mappings with
complexes.
known protein complexes; some of which are presented in Table 3 and highlighted
hereafter.Table 155: Selected complexes detected by ProRank+ when tested
on human protein-protein interaction dataset.Table 156: The
Matching
Detected
results of testing
ProRank+
on small
complexes.
Proteins
Members
of the
Detected Complex
Complex
Percentage
CCT micro{CCT3, CCT2, CCT8, CCT6A, CCT4, CCT7,
100 %
complex
CCT5, TCP1}
Table 157: Selected complexes detected by ProRank+ when tested
on human protein-protein interaction dataset.

Figure 374: Snapshots of a hypothetical PPI network, showing its
dynamics through different temporal, spatial and/or contextual
settings. Nodes and edges of the same color belong to the same
protein complex.Table 158: Selected complexes detected by
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{RPL32, RPS17, RPSA, RPL10A, RPL12,
Ribosomal
protein complex SLC25A5, RPL7, RPL18, RPL15, RPL21,
RPS6, RPS4X, RPL19, RPL14, RPL4, RPS27L,
RPS23, RPS26, RPS16, RPL7A, RPS24, RPS13,
RPS15A, RPS8, RPS3A, FAU, RPL11, RPL6,
RPL9, RPL5, RPS27, RPL17, RPS2, RPS25,
RPS20, NOP56, RPS15, RPL23A, RPS10,
RPL10L, RPLP0P6, RPS28, RPS5, RPS9,
RPL23, RPL18A, RPS3, RPL37A, RPL31,
RPL10, RPL8, RPS11, RPL36, RPS19, RPL30,
RPL24, RPS21, RPL27, RPS12, RPL29, RPS29,
RPS7, RPL22, RPLP0, RPS14, RPL3, RPLP2,
RPL27A, RPL13, RPS18, RPS27A}
PA700-20SPA28 complex

{PSMD8, PSMB2, PSMC3, PSMC4, PSMA4,
PSMA1, PSMD1, PSMD7, PSMA2, PSMB6,
PSMB7, PSMD3, PSMB1, PSMC1, PSMC5,
PSMC2, PSMB4, PSMA6, PSMD6, PSMD14,
PSMD12, PSMD11, PSMD13, PSMA7, PSMC6,
PSMA5, PSMB3, PSMB5, PSMA8, PSMD2}

SWItch/Sucrose
NonFermentable {SMARCA4, SMARCC1, ARID1A, SMARCE1,
SMARCC2, SMARCA2, SMARCB1}
(SWI/SNF)
complex

81.48 %

83.33 %

60 %

Table 3: Selected complexes detected by ProRank+ when tested on human
protein-protein interaction dataset.

Figure
Snapshots
of a hypothetical
network,
showing
dynamics in
1- 397:
The CCT
micro-complex
(Liou &PPI
Willison,
1997)
whichitsparticipates
through different temporal, spatial and/or contextual settings. Nodes and edges
proteincolor
folding,
assembly
transport.
is fully-detected197:
by ProRank+.
of the same
belong
to theand
same
proteinIt complex.Table
Selected
complexes detected by ProRank+ when tested on human protein-protein
2- Thedataset.
Ribosomal protein complex (Nakao, Yoshihama, & Kenmochi, 2004)
interaction
is detected with a 81.48 % match. Five additional proteins are detected:
SLC25A5,
RPS27L,
RPL10L,
and RPLP0P6.
association
Figure 398:
Snapshots
of a NOP56,
hypothetical
PPI network,
showingTheir
its dynamics
through different temporal, spatial and/or contextual settings. Nodes and edges
with the detected complex may be just noise or, on the contrary, can
of the same color belong to the same protein complex.
present biologically meaningful information.
Figure 399: Snapshots of a hypothetical PPI network, showing its dynamics
through different temporal, spatial and/or contextual settings. Nodes and edges
of the same color belong to the same protein complex.Table 198: Selected
complexes detected by ProRank+ when tested on human protein-protein
interaction dataset.
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3- The PA700-20S-PA28 complex (Kopp, Dahlmann, & Kuehn, 2001) is
detected with a mapping percentage of 83.33%. This complex is a key
component of the ATP-dependent proteolytic pathway in eukaryotic cells
and is responsible for the degradation of most cellular proteins.
4- A recent publication (Shain & Pollack, 2013) confirms that the mutations
of the SWItch/Sucrose NonFermentable (SWI/SNF) complex are
ubiquitous in various types of cancer. Accordingly, future research efforts
will put more focus on this tumor suppressor complex towards better
understanding of cancer diseases and in the direction of developing more
effective therapies. The SWI/SNF complex is composed of ten elements
distributed as follows: (a) SMARCA2 or SMARCA4, two mutuallyexclusive ATPase enzymatic subunits; (b) ARID1A, ARID1B, or PBRM1,
three mutually-exclusive subunits associated to functional specificity; (c)
core

and

accessory

subunits

including

SMARCB1,

SMARCC1,

SMARCC2, SMARCE1, SMARCD1, SMARCD2, or SMARCD3,
PHF10, DPF1, or DPF2, DPF3, and ACTL6A or ACTL6B. We map the
composition of SWI/SNF with the set of predicted complexes by
ProRank+. Our method is able to detect a complex consisting of the
elements SMARCA4, SMARCC1, ARID1A, SMARCE1, SMARCC2,
SMARCA2, SMARCB1. In comparison with the known structure of
SWI/SNF, ProRank+ correctly predicts six members out of ten
corresponding to 60 % of its subunits with a relatively low number of false
positives.
The above experiment affirms the ability of ProRank + to identify significant
and key protein complexes from protein interaction data. In addition, such outcomes
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can potentially contain relevant and previously-undiscovered protein complexes or
unidentified protein members of certain complexes.
3.4 Conclusion
ProRank+ is an efficient method for detecting protein complexes in proteinprotein interaction networks. The detection process is mainly centered on a ranking
algorithm that allows the identification of key proteins based on which the
corresponding components are formed. It is also tailored by a series of pruning,
filtering and merging steps, allowing the refinement of the drawn complexes. Unlike
most approaches, the design of our method is not bound by the sole association of
protein complexes to dense regions in interaction networks. In addition, ProRank+
takes into account possible overlaps among complexes and this is an important
assumption that reflects biological facts. In contrast with other methods, the
experimental study underlines the competitive ability of ProRank+ to identify protein
complexes. The performance of our algorithm is tested on weighted and un-weighted
datasets and using Human protein interaction data as well. The results greatly favor
our method.
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Chapter 4: Detecting Protein Complexes in Dynamic Protein-Protein
Interaction Networks
In this chapter we present our solution for the second research objective:
modeling the dynamic aspect of PPI networks and detecting protein complexes
accordingly. In section 4.1, we review the motivation of this objective and list the
advantages of modeling the dynamics of protein interaction networks. The DyCluster
method is introduced in section 4.2. The experimental study and results are presented
in section 4.3. Finally, the chapter is concluded in section 4.4.
4.1 Background
Early methods developed for the detection of protein complexes usually
model protein-protein interaction data as a static and all-inclusive network. However,
protein interactions do not occur at the same time (Macropol, Can, & Singh, 2009),
i.e. they are subject to various temporal, spatial and contextual settings. Accordingly,
instead of a single network representation, we would rather be looking at a series of
snapshots of a PPI network modeled based on either one or a combination of
conditions, as shown in Figure 13.
t1

t2

tn

Figure 13: Snapshots of a hypothetical PPI network, showing its dynamics
through different temporal, spatial and/or contextual settings. Nodes and edges
of the same color belong to the same protein complex.
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Novel experimental techniques can currently make such biological
information available. Hence, the shift from viewing PPI networks as static to
modeling the dynamics of these networks became fundamental (Przytycka, Singh, &
Slonim, 2010). Hereafter, we highlight some of the advantages of this transition.
First, it is a natural response to advances in experimental methods as it enhances the
replication of real biological events. Indeed, the more representative are the models
and the methods, the higher the accountability and the accuracy of the produced
results. Second, by combining different biological data, we can reach a
computational visualization level of protein interaction events that could verify or
even contradict biological concepts. Furthermore, previously unknown facts may be
learned, such as the characterization of hub proteins (Han et al., 2004) as “party
hubs” which interact with their partners at the same time or “date hubs” which
connect to their partners at different times and locations. In addition, integrating
multiple types of biological information allows overcoming data limitation issues.
For instance, PPI datasets are usually susceptible to high error rates (Reguly et al.,
2006); they may have missing interactions or may include spuriously-detected ones.
Moreover, possible enrichment data that can be used to model the dynamics of PPI
networks, such as gene expression profiles (Chen & Yuan, 2006) and gene ontology
(Xu, Lin, & Yang, 2010), suffer from low gene coverage in contrast with most PPI
datasets, in which the number of interacting proteins is typically very high (Von
Mering et al., 2002). The recurrence of information and/or inferences that are drawn
from different types of biological data can be seen as a confidence indicator. In view
of that, the integration of various datasets, even if not highly-credible, in the
direction of modeling PPI dynamics can potentially reduce the effect of false positive
and false negative rates, as well as low coverage issues. In contrast with static PPI
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networks, the information revealed by dynamic networks is at a higher level of
details. For instance, in the problem of identifying protein complexes, most of the
presented algorithms do not differentiate between functional modules and protein
complexes. That is mainly due to the absence of embedded information in the
networks that could guide the search. In fact, complexes are formed by proteins
which interconnect at the same time and place, whereas the members of functional
modules may interact at different times and places (Spirin & Mirny, 2003).
Accordingly, when PPIs are constrained by spatiotemporal conditions inferred from
gene expression and gene ontology datasets, for example, the detected components
could more likely be categorized as protein complexes or functional modules.
Likewise, dynamic PPI modeling may highly contribute to the detection of protein
subcomplexes. Various approaches were developed to solve this important research
problem, but all based on static networks (Zaki & Mora, 2014). As dynamic
modeling can reveal the mechanisms of protein-complex formation and can thus
yield better complex-detection approaches, it can also provide the same for the
detection of subcomplexes. Finally, since dynamic PPI networks better describe
protein interconnections, they can highly lead to better analytical results. The
integration of temporal, spatial or contextual biological information with PPI data as
a means to reproduce the PPI dynamics, can be viewed as clustering based on
temporal, spatial and/or contextual attributes. Hence, proteins and their interactions
can be grouped based on the integrated conditions and complex-detection methods
shall be applied accordingly, indeed with a generalization capability. Consequently,
the reliability of computational approaches is expected to increase.
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Based on the listed advantages, the next objective is to model the dynamic
aspect of PPI networks and then modify our complex-detection algorithm, ProRank+,
accordingly. Our approach is presented hereafter.
4.2 The DyCluster Method
The biological information that could be used to represent dynamic PPI
networks include, but are not limited to, gene expression data (Lovén et al., 2012)
which report quantitative measurement of RNA species in cellular compartments
across various conditions, subcellular localization annotations (de Lichtenberg,
Jensen, Brunak, & Bork, 2005) which provide spatial positions of elements in
cellular components; and gene ontology annotations (Ashburner et al., 2000) which
highlight genes that are present across different species. Time-series gene expression
data measure quantities of RNA across different time points in cellular processes.
Genes with correlated expressions across various conditions most likely interact.
Hence, the combination of time-series gene expression information with PPI data can
be used to model the dynamics of the PPI networks. For instance, that is done in
(Wang, Peng, Xiao, Li, & Pan, 2013), (Wang, Peng, Li, Luo, & Pan, 2011), (Li,
Chen, Wang, Wu, & Pan, 2014) and (Kim, Han, Choi, & Hwang, 2014); as
elaborated in the literature review (Chapter 3). Our proposed approach, DyCluster,
requires as input a gene expression dataset and a PPI dataset. It consists of five main
steps: biclustering gene expression data, extracting biclusters’ PPIs, pruning bicluster
PPIs, detecting protein complexes and finally, merging and filtering the sets of
detected protein complexes. An outline of the method is presented in Figure 14.
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Gene Expression Dataset
Biclustering Gene Expression
BC1

BC2

...

BCk

PPI Dataset
...
Extracting Bicluster PPIs
BC1_PPI BC2_PPI . . . BCk_PPI

Pruning Bicluster PPIs
Pruned Pruned
Pruned
...
BC1_PPI BC2_PPI
BCk_PPI

Detecting Protein Complexes
DC1

DC2

...

DCk

Merging and Filtering
Detected Protein Complexes
Figure 14: An outline of the DyCluster method.
4.2.1 Biclustering Gene Expression Data
A gene expression dataset shows the expression levels of a typically large
number of genes across different environmental conditions, time points, organs,
species, etc. It is conventionally represented as a matrix in which rows and columns
correspond to genes and their expression levels at different conditions or samples
respectively. It is assumed that genes which exhibit similar expression patterns
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across various conditions can be functionally-related (Baldi & Hatfield, 2002). The
analysis of these datasets is challenging because they are usually unbalanced, i.e. the
number of genes is quite larger than the number of conditions (Watson & Berry,
2009). Various approaches are proposed to analyze expression data and to group
genes according to their expression patterns; in particular, data mining approaches
such as classification and clustering. Classification methods require knowing the
label of the resulting classes in advance, which somehow limits the process of data
exploration. Nevertheless, several research efforts study the application of such
supervised techniques on gene expression data (Asyali, Colak, Demirkaya, & Inan,
2006). Likewise, typical clustering techniques have two drawbacks when applied to
gene expression data (Jiang, Tang, & Zhang, 2004): first, each gene must be placed
in a cluster even if its similarity with other cluster members is relatively low; second,
a gene can belong to one cluster only. Consequently, these techniques cannot account
for the fact that a large number of genes can exhibit multiple biological functions
(Hodgkin, 1998), and thus can belong to more than one cluster. Besides, clustering
spans the whole sample set whereas in reality, the expression levels of a gene cluster
may be correlated based on a subset of samples. Thanks to the simultaneous twodimensional clustering capability which they provide, biclustering techniques present
better means to explore expression data (Madeira & Oliveira, 2004). In fact, they
allow the identification of subsets of co-regulated genes across subsets of samples.
Added to that, in analogy to biological facts, a gene may belong to multiple clusters
or may not fit in any cluster in some cases.
A problem formulation of biclustering gene expression data is as follows: Let
A be an n*m data matrix, representing a gene expression dataset consisting of n
genes measured across m conditions; aij being a real value corresponding to the
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expression level of the gene at row i and the condition at column j. The goal is to find
a set of biclusters BC(I, J); where I is a subsets of genes which exhibit similar
expression patters across the subset of conditions J.
We highlight some of the existing biclustering approaches which are also used later
to evaluate the DyCluster method. Biclustering is first applied on gene expression
data by Cheng and Church (Cheng & Church, 2000). Their method, CC, consists of a
greedy search heuristic to form the biclusters, namely the set covering algorithm, and
uses the Mean Square Residue (MSR) measure to assess the biclusters’ quality based
on a specified threshold. The MSR of a bicluster BC, of I rows and J columns,
reflects the degree of coherence between the genes and the conditions which it
includes. It is calculated based on equation (6) where bcij, bciJ, bcIj and bcIJ represent
the elements in row i and column j, the row and the column means, and the mean of
BC, respectively.
|𝐼|

|𝐽|

1
2
𝑀𝑆𝑅(𝐵𝐶) =
∑ ∑(𝑏𝑐𝑖𝑗 − 𝑏𝑐𝑖𝐽 − 𝑏𝑐𝐼𝑗 + 𝑏𝑐𝐼𝐽 )
|𝐼||𝐽|

(11)

𝑖=1 𝑗=1

The lower the MSR, the higher is the bicluster coherence. Correlations among
genes can be expressed in terms of scaling and shifting patterns. A robustness
characteristic of a biclustering algorithm, when applied on expression data, is in its
ability to capture both types of patterns. MSR can only detect shifting
correspondences among the expression levels of genes (Bozdağ, Kumar, &
Catalyurek, 2010). Despite that, it is used by several similar approaches and some
variants of this measure are also introduced to identify the scaling patterns
(Mukhopadhyay, Maulik, & Bandyopadhyay, 2009). The Order Preserving Sub
Matrix (OPSM) algorithm (Ben-Dor, Chor, Karp, & Yakhini, 2003) searches for
large submatrices in which genes have the same linear ordering of the samples. The
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Iterative Signature Algorithm (ISA) (Bergmann, Ihmels, & Barkai, 2003) uses the
signature algorithm to identify self-consistent transcriptional modules consisting of
co-expressed genes and the samples corresponding to them. A comprehensive survey
of these methods can be found in (Madeira & Oliveira, 2004).
4.2.2 Extracting Bicluster PPIs
Given the set of gene biclusters, BC = {BC1(I1, J1), BC2(I2, J2), ...,BCk(Ik, Jk)},
the next step consists of finding the interconnections among the members of each
bicluster based on a specified PPI dataset. The interactions involving elements that
belong to the set of proteins in each bicluster are extracted.
4.2.3 Pruning Bicluster PPIs
PPI datasets are usually noisy (Marto, 2009). As a result, many methods are
developed to prune PPI data and thus to reduce their levels of false positives and
false negatives such as (Chua et al., 2008) and (Zaki, Efimov, & Berengueres, 2013).
Here, we use the PE method introduced by Zaki et al. to assess the reliability of
protein interactions at the level of generated biclusters and to prune the
corresponding PPI subsets accordingly. Experiments show that PE-measure is
efficient as it reduces the level of noise in protein interaction networks by looking for
subgraphs that are closest to maximal cliques, based on the weighted clustering
coefficient measures.
4.2.4 Detecting Protein Complexes
Successively, a protein-complex detection method is applied on the pruned
biclusters PPIs, disjointedly on each bicluster. Therefore, several sets of identified
protein complexes are formed, DC1, DC2, ..., DCk.
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4.2.5 Merging and Filtering
Merging and filtering the resultant sets of complexes is crucial to the overall
accuracy of our approach. However, developing an appropriate post-processing
method is challenging because it is subject to various considerations. For instance, in
its simplest form, it may consist of matching the detected entities against each other
and combining the ones which have an overlap greater than a certain threshold. In
contrast, keeping the common members of highly-overlapping entities may also be
explored and it might lead to better outcomes. Another approach may think through
the core-attachment interpretation of complexes (Gavin et al., 2006) and consider
that a repeated subgroup of interacting proteins in several detected groupings may be
a potentially correct core, which forms different complexes when linked with various
protein attachments. Nonetheless, in our paper, we keep this task for later research
stages and we hereby limit the formation of the combined set of complexes to
merging based on an overlap threshold and a condition by which members of one
complex interact with a certain percentage of members of the other complex; in
addition to filtering duplicates. This step finalizes the complex-detection process.
4.3 Experimental Study
4.3.1 Datasets
DyCluster requires a gene expression dataset to model the dynamic aspect of
protein interactions and a PPI dataset from which the interconnections among those
proteins are extracted. Certainly, the higher the homogeneity of both datasets,
namely in terms of the species and the number of common genes that they cover, the
better are the expected outcomes. We refer to Gene Expression Omnibus (GEO)
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repository (Barrett et al., 2013) from which we select the expression dataset of
accession number GSE3431 (Tu, Kudlicki, Rowicka, & McKnight, 2005), entitled
“Logic of the yeast metabolic cycle”. It reports the expression levels of genes across
twelve time intervals in three successive metabolic cycles. Our choice is primarily
based on its wide coverage of yeast proteins and potentially, a high number of
participants in various cellular processes. The yeast PPI dataset is downloaded from
the Database of Interacting Proteins (DIP) (Xenarios et al., 2002) catalogue of
experimentally-determined protein interactions. Finally, we compare our results to
the CYC2008 catalogue (Pu et al., 2009) containing 408 complexes, as reference set
of yeast protein complexes.
4.3.2 Evaluation Scores
The quality scores, used to evaluate our approach, include: (a) the number of
complexes in the reference catalogue that are matched with at least one of the
predicted complexes with an overlap score, OS ≥ 0.2; (b) the clustering-wise
sensitivity (Sn) and (c) the clustering-wise positive predictive value (PPV) used to
calculate the matching quality, mainly in terms of the correctly-matched protein
members among the detected complexes; (d) the geometric accuracy (Acc) which is
the geometric mean of Sn and PPV; and (e) the maximum matching ratio (MMR)
which measures the maximal one-to-one mapping between predicted and reference
complexes by dividing the total weight of the maximum matching with the number
of reference complexes. Note that the same measures are used to evaluate the
ProRank+ method, introduced in the previous chapter.
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4.3.3 Algorithms
For the gene expression biclustering step, we use three algorithms: OPSM
(Ben-Dor, Chor, Karp, & Yakhini, 2003), CC (Cheng & Church, 2000) and ISA
(Bergmann, Ihmels, & Barkai, 2003). Here, we note that although efforts are spent in
the direction of finding suitable ways to evaluate biclustering approaches (Oghabian,
Kilpinen, Hautaniemi, & Czeizler, 2014), comparing their performances is still a
challenging task. Added to that, in order to shed the light on the advantage of using
gene expression data, we also examined the results of applying the framework using
the one-way clustering method k-means (Hartigan & Wong, 1979), based on
Pearson’s correlation as a distance measure. The parameters settings of these
algorithms are presented in Table 4. We used the BicAT tool (Barkow et al., 2006) to
visualize and perform the biclustering of the gene expression dataset.

CC
OPSM
ISA

K-means

Parameter Settings
upper limit of MSR:  = 0.5
threshold for multiple node deletion:  = 1.2
number of output biclusters = 10
number of passed models for each iteration: l = 10
threshold of genes: t_g = 0.5
threshold of chips: t_c = 0.5
number of starting points = 100
distance measure: Pearson’s correlation
number of clusters = 10
number of iterations = 100
number of replications = 1

Table 4: Parameter settings of the biclustering algorithms.
For the step consisting of pruning the PPI data at the biclusters levels, we
Table
310:(Zaki,
Experimental
of matching
the default
sets ofparameters,
apply the PE
method
Efimov, &results
Berengueres,
2013) with
protein complexes, detected by the DyCluster framework,
specifically,against
with edges
scorereference
threshold equals
to 0.1. In terms
the reliability
CYC2008
catalogue.Table
311: of proteinParameter settings of the biclustering algorithms.
complex detection methods, we use ProRank (Zaki, Berengueres, & Efimov, 2012a),
ProRank+ (Hanna & Zaki, 2014), ClusterONE (Nepusz, Yu, & Paccanaro, 2012) and
Table 312: Experimental results of matching the sets of
protein complexes, detected by the DyCluster framework,
against the CYC2008 reference catalogue.
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CMC (Liu, Wong, & Chua, 2009), MCODE (Bader & Hogue, 2003) and CFinder
(Adamcsek et al., 2006). ProRank, ProRank+, ClusterONE and CFinder are applied
with default parameters. For CMC, the overlap and the merging thresholds are set to
0.75 and 0.5, respectively. For MCODE, degree cutoff, node score cutoff, k-core and
maximum depth from seed are set to 2, 0.2, 2 and 3, respectively.
Added to that, the generated sets of detected complexes are examined and
refined as follows: if two complexes have a number of overlapping members greater
than 75% of the size of the smaller complex; and if the members of the first complex
interact with at least 50% of the members of the second complex, then they are
merged.
4.3.4 Results
According to the presented framework, the gene expression dataset,
GSE3431, is processed by the three biclustering algorithms, OPSM, CC and ISA,
and by the k-means clustering algorithm, one at a time. The PPIs corresponding to
the proteins contained in each of the resulting biclusters are extracted from the
specified yeast PPI dataset and are pruned using PE technique. The protein complexdetection methods, listed above, are applied on the generated biclusters. Finally, the
detected sets of complexes are merged, filtered and matched against the CYC2008
reference catalogue. Table 5 shows the corresponding results in terms of the number
of matched protein complexes and the number of detected complexes along with the
corresponding evaluation scores. For comparison purpose, the table also includes the
results of just applying the detection algorithms on the PPI dataset, excluding the
gene expression data.
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CFinder

Mcode

CMC

ClusterONE

ProRank+

ProRank

No. of
No. of
Biclustering
Method
matched detected
Algorithm
complexes complexes
41
230
None
335
OPSM
78
CC
252
63
ISA
320
71
331
K-means
71
46
274
None
397
OPSM
81
305
CC
65
392
ISA
78
424
K-means
78
76
365
None
929
OPSM
89
578
CC
78
890
ISA
87
862
K-means
83
114
4292
None
OPSM
100
1207
95
1145
CC
ISA
100
1843
94
1126
K-means
62
168
None
475
OPSM
71
60
285
CC
315
ISA
63
448
K-means
74
116
6381
None
94
2079
OPSM
CC
98
1236
99
2119
ISA
K-means
99
1352

Acc

Sn

MMR

PPV

0.4715
0.5911
0.5658
0.564
0.556
0.4788
0.5982
0.5668
0.5677
0.5687
0.6008
0.6426
0.6267
0.6015
0.6153
0.6587
0.6159
0.5983
0.6041
0.6088
0.55
0.5695
0.545
0.5529
0.5658
0.6143
0.6187
0.5977
0.5738
0.5988

0.3072
0.4627
0.4296
0.4332
0.4222
0.3371
0.5116
0.4724
0.4719
0.4782
0.511
0.5758
0.5465
0.5506
0.533
0.6517
0.5566
0.5264
0.5518
0.5542
0.4271
0.4602
0.4058
0.4232
0.4583
0.5641
0.525
0.559
0.5393
0.5455

0.1032
0.2103
0.1804
0.195
0.1896
0.1161
0.225
0.1947
0.2231
0.2196
0.2349
0.2469
0.2036
0.2499
0.2334
0.347
0.2903
0.2844
0.3071
0.2913
0.149
0.1835
0.1581
0.171
0.1947
0.3776
0.2925
0.3005
0.3021
0.3098

0.7237
0.755
0.7451
0.7342
0.7322
0.6801
0.6995
0.6802
0.683
0.6764
0.7064
0.7172
0.7186
0.6571
0.7102
0.6658
0.6816
0.6801
0.6614
0.6689
0.7082
0.7049
0.7321
0.7222
0.6986
0.669
0.7291
0.6391
0.6104
0.6574

Table 5: Experimental results of matching the sets of protein complexes,
detected by the DyCluster framework, against the CYC2008 reference
catalogue.

4.3.5 Case Study
Table 389: The detected components by the DyCluster framework when
applied on the Rattus norvegicus datasets.Table 390: Experimental results of
matching
complexes,
detected by
DyCluster
Next, the
we sets
test of
theprotein
effectiveness
of DyCluster
onthe
a network
of framework,
140 key genes
against the CYC2008 reference catalogue.
involved in programmed cell death in Rat Apoptosis (RT2 Profiler PCR Array Rat
Apoptosis, PARN-012A) and inflammation (RT2 Profiler PCR Array Rat
Table 391: The detected components by the DyCluster framework when
applied on the Rattus norvegicus datasets.

Table 392: The topological features of genes and their definitions.Table 393:
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Inflammatory Cytokines and Receptors, PARN-011A). All the 140 genes are
processed using String 9.1 (http://string-db.org/) (Jensen et al., 2009). String is a
biological database and web resource of known and predicted protein-protein
interactions. All the corresponding proteins and their interactions are retrieved and
the network was built. Once the PPI network including 1413 interactions and 140
proteins related to the Rattus norvegicus species is build, several enrichment features
available in String 9.1 (features related to KEGG pathway, Reactome Pathway,
Molecular function, Pfam domain, InterPro-Domains) are used to generate several
sub-networks/groups which were then considered as protein complexes. The idea
here is to see whether DyCluster is capable of detecting such groups of biologically
related proteins given only the PPI network information.
In this experiment, the gene expression data set, of accession number
GSE17384, is downloaded from the GEO (Barrett et al., 2013) repository. It is
entitled: “Gene expression data from the LEC rat model with naturally occurring and
oxidative stress induced liver tumorigenesis”. It reports the variations of gene
expression levels in a stepwise manner from the normal liver condition, to chronic
oxidative stress-induced hepatitis and liver tumor by time-series microarray analysis.
In other words, the study involves a comparison between normal liver tissues and
developed liver tumors at different time points. It can potentially reveal genes which
participate in the progressive formation of the disease. The OPSM method (Ben-Dor,
Chor, Karp, & Yakhini, 2003) is used to bicluster the gene expression data since it
shows a relatively good performance in our experimental study.
Then, we examine the results for potential matching with the reference
subnetworks/groups generated using String. Table 6 shows the detected components
by DyCluster framework, listed by types, along with their matching percentages. The
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experimental results thus confirm the potential of our approach in detecting and
understanding protein entities of key roles in normal and abnormal cellular functions.
Matching
Percentage
Chemokine receptor family
100%
G protein-coupled receptor, rhodopsin-like
100%
GPCR, rhodopsin-like, 7TM
100%
BLC2 family
83.3%
InterPro- BLC2-like
83.3%
Domains Death effector domain
66.7%
Interleukin-6 receptor alpha, binding
50%
Death domain
100%
Apoptosis regulator, Bcl-2, BH2 motif, conserved site
75%
Chemokine interleukin-8-like domain
60%
Chemokine signaling pathway
40%
Cytokine-cytokine receptor interaction
32.8%
NOD-like receptor signaling pathway
31.3%
Apoptosis
34.4%
Autoimmune thyroid disease
71.4%
KEGG
66.7%
Pathway Huntington's disease
Systemic lupus erythematosus
40%
Asthma
50%
Intestinal immune network for IgA production
25%
Cell adhesion molecules
50%
Pathways in cancer
70%
Peptide receptor activity
58.3%
Receptor activity
52.2%
Growth factor activity
60%
66.7%
Molecular C-C chemokine binding
40%
Function Tumor necrosis factor receptor superfamily binding
Death effector domain binding
66.7%
Growth factor binding
50%
Nucleic acid binding transcription factor activity
75%
Chemokine activity
77.8%
7 transmembrane receptor, rhodopsin family
100%
Apoptosis regulator proteins, Bcl-2 family
83.3%
Pfam
Death effector domain
66.7%
Domains Interleukin-6 receptor alpha chain, binding
50%
Small cytokines (intecrine/chemokine), interleukin-8 like
53.3%
Death domain
100%
Activation of DNA fragmentation factor
66.7%
Interleukin-1 family precursors are cleaved by caspase-1
100%
Detected Component
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Downstream TCR signaling
FasL/CD95L signaling
Reactome
Exocytosis of platelet alpha granule contents
Pathway
IRAK4 is activated by autophosphorylation
Beta defensins
TRAIL signaling
Interleukin-1 processing
FASL:FAS Receptor Trimer, FADD complex

100%
100%
100%
75%
66.7%
66.7%
75%
100%

Table 6: The detected components by the DyCluster framework when applied on
the Rattus norvegicus datasets.
4.4 Conclusion
Table DyCluster
460: The is
topological
features
ofdetection
genes and
definitions.Table
461:
a framework
for the
of their
protein
complexes in dynamic
The detected components by the DyCluster framework when applied on the
protein
Rattusinteraction
norvegicusnetworks
datasets. modeled by incorporating gene expression data, through
biclustering techniques. It responds to the important shift from interpreting PPI data
462:static
The topological
of genes
and their definitions.
asTable
a single
network tofeatures
modeling
and exploring
the dynamic nature of these
networks. Our approach is tested using several biclustering techniques and various
Table 463: The topological features of genes and their definitions.Table 464:
protein complex detection methods. As the experimental results show, the
The detected components by the DyCluster framework when applied on the
Rattus norvegicus
datasets.
incorporation
of gene
expression data in the process of detecting protein complexes
in dynamic PPI networks is indeed beneficial, in contrast with the detection of
Table 465: The topological features of genes and their definitions.Table 466:
complexes in static networks. On one hand, it can notably increase the correctness
The detected components by the DyCluster framework when applied on the
Rattus
and
the norvegicus
quality ofdatasets.
the results, as it is the case for ProRank, ProRank+ and
ClusterONE where the numbers of matched complexes, Acc, Sn, PPV and MMR are
Table 467: The topological features of genes and their definitions.
higher. On the other hand, biclustering genes based on their expression patterns can
significantly reduce the large number of complexes detected by some algorithms,
Table 468: The topological features of genes and their definitions.
such as CMC and CFinder, while not compromising the quality of the outcomes. The
framework models the dynamic aspect of PPI networks by grouping proteins
Table 469: The topological features of genes and their definitions.
according to the similarities of their expression patterns across subsets of conditions.
Moreover, it is not restricted by threshold imposition on gene expression levels. As
Table 470: The topological features of genes and their definitions.Table 471:
The detected components by the DyCluster framework when applied on the
Rattus norvegicus datasets.
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mentioned earlier, biclustering approaches are better than conventional clustering
methods when it comes to expression data analysis. Nonetheless, the results attained
by DyCluster using the k-means clustering algorithm accentuate the improvement
which can be gained by incorporating gene expression information to model the
dynamics of PPI interactions and to detect protein complexes in PPI networks
accordingly. Finally, the produced results in our case study are in favor of the
DyCluster framework.
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Chapter 5: Gene-Disease Association through Topological and Biological
Feature Integration
In this chapter, we present our gene-disease association approach.
Background information is presented in section 5.1. The building blocks of our
learning model are discussed in section 5.2. The experimental study is shown in
section 5.3. A case study in which we apply our approach on the Diabetes Mellitus,
Type II disease is presented in section 5.4. The chapter is concluded in section 5.5.
5.1 Background
The huge amounts of information generated using high-throughput
experimental techniques continue to motivate the design of suitable methods for
valuable biological knowledge mining. In particular, the identification of the genes
and the inter-molecular events leading to the formation of diseases remains essential
towards the development of effective medical therapies. The association of genes to
one disorder accelerates the linkage of key players to other diseases. Full insights
about the formation processes of most diseases are still incomplete. Based on the
assumption that genes related to similar disorders tend to be functionally associated
(Oti & Brunner, 2007) (Wu, Jiang, Zhang, & Li, 2008), existing methods often
follow the notion of guilt-by-association (Altshuler, Daly, & Kruglyak, 2000) by
which genes are ranked based on their similarity to known disease genes. The
literature contains numerous approaches designed to link genes to diseases. We
hereafter recall some of them. Deng et al. (Deng, Chen, & Sun, 2004) build an
integrated probabilistic model to predict protein functions based on their physical and
genetic interconnections, in addition to gene expression networks and known protein
complexes. Xu and Li (Xu & Li, 2006) apply the k-nearest neighbor algorithm to
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identify disease-related genes based on PPI network topology features. Ma et al. (Ma,
Lee, Wang, & Sun, 2007) prioritize disease genes using a method based on Markov
Random Field (MRF), applied on gene expression profiles and protein interaction
datasets. Lage et al. (Lage et al., 2007) integrate phenotypic data and phenotypic
similarities with a high-confidence human protein interaction network and use a
Bayesian classifier to link previously-unknown protein complexes to diseases.
Köhler et al. (Köhler, Bauer, Horn, & Robinson, 2008) apply a random walk with
restart algorithm (RWR) on a heterogeneous interaction network to prioritize
candidate disease genes. Li and Agarwal (Li & Agarwal, 2009) answer the gene
prioritization problem by looking for disease relationships via literature mining to
identify disease genes. Zhang et al. (Zhang, Li, Tai, Li, & Chen, 2012) classify genes
based on various PPI network topology features. Guan et al. (Guan et al., 2012)
create tissue-specific functional networks to prioritize disease genes. Li et al. (Li et
al., 2014) introduce novel topological attributes and use support vector machines
(SVM) to classify genes as disease-related or not. Chen et al. (Chen B. , Wang, Li, &
Wu, 2014) combine biological data from multiple sources in order to prioritize
disease genes; they develop a method based on the Markovian random field theory
and Bayesian analysis. Many existing approaches have good performance. However,
they mainly require initial setting of parameters and thresholds in addition to the
dependence on a single kind of gene features, either topological or biological.
We present a learning model which classifies genes as disease-related or not,
based on both topological and biological features. Given a list of genes, the goal is to
maximize the contrast between disease and non-disease classes. Accordingly, we
study the topology of the corresponding PPI network to find distinctive positioning
of genes and we combine biological data from various sources to discover potential
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similarities which characterize each class. Our proposed approach scores an area
under the receiver operating characteristic (ROC) curve of 0.941 when applied using
the Naïve Bayes classifier on a multiple disease dataset.
5.2 Gene Features
Recent advances in experimental technologies, in general, and in nextgeneration sequencing, in particular, offer great means for the identification of
disease-related genes (Mardis, 2008). Large amounts of informative biological data
can be easily generated nowadays. Nonetheless, fully perceiving various molecular
processes still requires the assistance of computational techniques for the analysis
and the integration of heterogeneous data. Based on the characteristics of reference
disease genes, the goal is to shortlist other genes which could most likely be related
to diseases, for further experimental explorations. In our study, we develop a model
to classify genes as disease-related or not according to common PPI network
topology attributes and various biological features shared by each type. We believe
that by gathering computationally-conveyed network study and experimentallygenerated biological information, we can enhance the gene-disease association
process.
5.2.1 Topological Features
Mutations in interacting proteins often lead to similar phenotypes.
Accordingly, PPI networks in which proteins and their interconnections are
represented as nodes and edges respectively, significantly reflect the functional
associations among genes (Xu & Li, 2006). Studying PPI networks to extract the
topological features can greatly expedite gene-disease association tasks. In view of
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that, given a set of genes to classify, we examine the corresponding PPI network and
compute the topological features of the nodes, as described in Table 7.
Topological
Features

Description

Degree

Number of edges that are adjacent to a node

The distance from a node to the farthest node from it in
the network
The average distance from a node to all other nodes in
Closeness
the network
Centrality
Betweenness The number of times a node appears on shortest paths
between nodes in the network
Centrality
Eccentricity

Authority

The value of the information stored at a node

Hub

The quality of a node’s links

Modularity
Class

The class reflecting how well a network decomposes
into modular communities

PageRank

The rank of a node by its importance in the network

Component
ID
Clustering
Coefficient
Number of
triangles
Eigenvector
Centrality

The number of connected components to a node in the
network
The completeness of the neighborhood of a node in the
network
The number of connected triangles including a certain
node
The importance of a node in the network based on its
connections

Table 7: The topological features of genes and their definitions.
5.2.2 Biological Features
Table 507: The topological features of genes and their definitions.
Various experimental observations can be viewed as sources of descriptive
evidences that could potentially tell apart disease from non-disease genes (Piro & Di
Table 508: The topological features of genes and their definitions.
Cunto, 2012). Hence, the more attributes we include, the larger the potential contrast
between gene classes. The biological features of genes considered in our study are
Table 509: The topological features of genes and their definitions.
presented hereafter.
Table 510: The topological features of genes and their definitions.

Table 511: The topological features of genes and their definitions.

Table 512: The topological features of genes and their definitions.
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1- Sequence Length: Previous studies show that disease genes tend to have
longer sequences (Mushegian et a., 1997). In view of that, the number of
amino acids in the canonical gene sequence is examined.
2- Gene Ontology (GO) Terms: The GO project (Ashburner et al., 2000)
provides a set of hierarchically-controlled vocabulary that describes gene
products in terms of their biological processes, molecular functions and
cellular components. Biological processes cover the gene molecular events
related to the functioning of integrated living units including cells, tissues,
organs, and organisms. Molecular functions delineate the elemental
activities of a gene product at the molecular level. Cellular components are
the parts of a cell or its extracellular environment in which the gene
resides.
3- Topological Domains: The topology and the compartments of proteins in
the cell can potentially take part in disease or non-disease gene
classification (Ibn-Salem et al., 2014). In particular, the topological
domain information which describes the subcellular compartments where
each non-membrane region of a membrane-spanning protein is found.
4- Chain: This feature shows the extent of a polypeptide chain in the mature
protein following processing. It can also provide an insight on whether a
protein is related to disease or not (Park & Park, 2015).
5- Domain: Defined as a specific combination of secondary structures
organized into a characteristic three-dimensional structure or fold, protein
domains

usually

correspond

to

structural

independently of the rest of the protein chain.

domains

which

fold
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6- Protein Family: Under the assumption that proteins belonging to the same
family share common evolutionary origins and thus exhibit similar
functions (Wu, Huang, Yeh, & Barker, 2003); we take into account protein
family groupings in our classification process.
7- Pathway: Considering the pathways in which genes participate could
potentially direct the association of genes to diseases.
5.3 Experimental Study
5.3.1 Data Sources and Feature Collection
We refer to the paper by Goh et al. (Goh et al., 2007) to extract the genedisease association data which reports 1777 genes linked to 1284 disorders split into
22 types. This data is originally derived from the Online Mendelian Inheritance in
Man (OMIM) database (McKusick, 2007). We preprocess the dataset as reported in
the paper by Chen et al. (Chen B. , Wang, Li, & Wu, 2014), namely, by removing the
genes related to “multiple”, “unclassified”, “cancer”, “neurological” diseases in
addition to the disease types of less than 30 gene members. The PPI dataset is
extracted from the Human Protein Reference Database (HPRD) (Prasad et al., 2009)
which originally comprises 37039 edges. We use the PE method presented in (Zaki,
Efimov, & Berengueres, 2013) to assess the reliability of protein interactions and
clean the PPI data accordingly. As a result, the final learning dataset consists of 9228
genes out of which 839 are associated to diseases.
We use Gephi (Bastian, Heymann, & Jacomy, 2009), the interactive
visualization and exploration platform, to study the PPI network and compute the
topological features of the genes as listed in Table 7. Next, we consult the Universal
Protein Resource (UniProt) (UniProt Consortium, 2014) to extract the biological
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features of the genes. UniProt is a comprehensive resource that captures accurate and
consistent information on proteins including, but not limited to, accepted biological
ontologies, classifications and cross-references. Sequence length, chain and domain
attributes are directly retrieved and added to the learning dataset. Some
preprocessing is required for the rest of the biological characteristics which are
multi-valued and comprise a large number of possible descriptions. Accordingly and
since we are interested in identifying disease genes, we look for distinctive top
feature values describing them. For instance, we look for the top 25 GO biological
processes, molecular functions and cellular components associated to disease genes
in the learning dataset, convert them to Boolean attributes and find the values

Genes

GO Biological Process
v1

v2

g2

v1

v3

g3

v2

Genes
g1

v4
...

g2

1

1

1

g3

0

0

0

...

...

g1

Top 25 GO Biological Processes
v1 v3 v4 ...
1
0
0

Figure 15: Conversion to Boolean attributes.

The same applies for GO molecular functions, GO cellular components,
Protein Family and Pathway. Protein family information is based on PROSITE
database of protein domains, families and functional sites (Sigrist et al., 2012).
Pathway information is based on the Reactome Pathway Database (Croft et al.,
2014). The number of Topological Domains associated to the genes under
consideration is relatively lower. For this reason, we pick the top 3 domains and
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convert them to Boolean features in the same manner; they are “cytoplasmic”,
“lumenal” and “extracellular”. In total, we have 9228 genes with 142 features.
5.3.2 Classification Model and Results
After assembling the components of our learning dataset, we develop a
classification model based on the Naïve Bayes classifier (John & Langley, 1995). We
use the Weka data mining software (Hall et al., 2009). The generated results are
based on default parameters of the Naïve Bayes classifier with a 10-fold crossvalidation process. Table 8 and Table 9 represent the confusion matrix and the
classification scores, respectively. The ROC curve is an essential indicator of the
classification quality (Zweig & Campbell, 1993). It reflects the classifier's ability to
distinguish between classes by plotting the true positive rate against the false positive
rate across various thresholds. The ROC curve of our Naïve Bayes classification is
presented in Figure 16. It corresponds to an area under curve (AUC) of 0.941.
Non-Disease
Genes
Non-Disease Genes
7858
149
Disease Genes
Classified as

Disease
Genes
531
690

Table 8: The confusion matrix showing the number
of correctly-classified and the incorrectly-classified
instances per class.
Class Precision Recall F-Measure AUC
0.981
0.937
0.959
Non-Disease Genes
Table 522: The classification scores of our gene 0.941
0.565
0.822
0.67
Disease Genes
classification model.Table 523: The confusion
the number
Table matrix
9: Theshowing
classification
scoresofofcorrectly-classified
our gene classification
model.and the incorrectly-classified instances per class.

524:classification
The classification
of ourclassification
gene
Table Table
569: The
scores scores
of our gene
model.classification model.

525:classification
The classification
of ourclassification
gene
Table Table
570: The
scores scores
of our gene
model.classification model.Table 526: The confusion
matrix showing the number of correctly-classified

True Positive Rate
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False Positive Rate
Figure 16: The ROC curve of our learning model, it
corresponds to an AUC score of 0.941.

We compare the outcome of our approach to the experimental results
presented in (Chen B. , Wang, Li, & Wu, 2014) in which several disease-gene
identification methods are applied on the same gene-association dataset. Those
methods include: IMRF2 (Chen B. , Wang, Li, & Wu, 2014) which uses the theory of
Markov Random Field (MRF) and Bayesian analysis to integrate data from various
sources; MRF-Deng (Deng, Chen, & Sun, 2004) which is also based on MRF; the
Random Walk with Restart (RWR) algorithm (Köhler, Bauer, Horn, & Robinson,
2008) proposed to identify disease genes by combining multiple PPI networks; and
the method by Chen et al. (Chen et al., 2011) who define a Data Integration Rank
(DIR) score to find key information in integrated data. DIR has the best performance
when compared to previous approaches (Chen et al., 2011). The AUC score
comparisons are presented in Table 10 and our approach clearly has better diseasegene association results.
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IMRF2 MRF-Deng RWR DIR
0.551
0.676 0.691
AUC 0.743

Our Model
0.941

Table 10: AUC score comparison of our model with
previous approaches.
5.4 Case Study: Diabetes Mellitus, Type II disease
Table 682: The confusion matrix showing the number of
correctly-classified
and theofincorrectly-classified
In order
to test the performance
our proposed model,instances
we consider the case
per class in our Diabetes Mellitus, Type II case study.Table
study of the Diabetes
Mellitus,
Type II disease
which
is a metabolic
disorder marked
683: AUC
score comparison
of our
model
with previous
approaches.
by high blood sugar and a lack of insulin in the body (Chen, Magliano, & Zimmet,
2012). The occurrence of this disease is continuously growing making it one of the
Table 684: The confusion matrix showing the number of
major healthcare
challenges around
theincorrectly-classified
world. We consult instances
the OMIM database
correctly-classified
and the
per class in our Diabetes Mellitus, Type II case study.
(McKusick, 2007), and extract the genes associated to the Diabetes Mellitus, Type II
(OMIM: 125853). Next, in terms of PPI data, we refer to HPRD (Prasad et al., 2009).
Table 685: The confusion matrix showing the number of
We collect the
corresponding topological
and biological features
of the genes, as
correctly-classified
and the incorrectly-classified
instances
per class in our breast cancer case study.Table 686: The
described in our approach. Consequently, a learning dataset is formed; it consists of
confusion matrix showing the number of correctlyclassified
and
the23incorrectly-classified
instances
per class
9166 genes out
of which
only
are related to the Diabetes
Mellitus,
Type II disease.
in our Diabetes Mellitus, Type II case study.Table 687:
We consistently
a 10-fold
cross-validation
AUCusescore
comparison
of our Naïve
model Bayes
with classifier
previous to build the
approaches.
model. The resultant confusion matrix is shown in Table 11. It corresponds to an
AUC score of 0.895.
Table 688: The confusion matrix showing the number of
correctly-classified and theNonincorrectly-classified
instances
Diabetes
Diabetes
Classified as
Genes
Genes
per class in our Diabetes Mellitus,
Type II case study.Table
Non-Diabetes
9027
689:
AUC score Genes
comparison of
our model with 116
previous
8
Diabetes
Genes
15
approaches.
Table 11: The confusion matrix showing the number of
correctly-classified and the incorrectly-classified instances
Table 690: The confusion matrix showing the number of
per class in our Diabetes Mellitus, Type II case study.
correctly-classified and the incorrectly-classified instances
per class in our Diabetes Mellitus, Type II case study.
The attained results are in favor of the presented model which can identify 15
Table 762: The confusion matrix showing the number of
of the Type II Diabetes genes, equivalent to 65.2%. In comparison, our model has a
correctly-classified and the incorrectly-classified instances
Table 691: The confusion matrix showing the number of
per class in our breast cancer case study.Table 763: The
correctly-classified and the incorrectly-classified instances
confusion matrix showing the number of correctlyper class in our breast cancer case study.Table 692: The
classified and the incorrectly-classified instances per class
confusion matrix showing the number of correctlyin our Diabetes Mellitus, Type II case study.
classified and the incorrectly-classified instances per class
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better performance than the method by Chen et al. (Chen, Wu, & Jiang, 2013) which
predicts 13 Type II Diabetes genes.
5.5 Conclusion
Finding suitable methods for the identification of disease genes remains
essential towards understanding how various disorders are formed and ultimately
finding appropriate medical treatments. Our solution integrates topological features
calculated

based

on

PPI

network

analysis

with

various

biological

information/features of genes stored in multiple databases. Our experimental work
verifies our initial hypothesis. By combining computationally-conveyed network
study and experimentally-generated biological information, we can enhance the
gene-disease association process.
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Chapter 6: A Comprehensive Case Study: Breast Cancer
6.1 Background
In this chapter, we present a comprehensive case study on which we apply the
approaches introduced in this dissertation. The main question that we would like to
answer here is: by applying our gene-disease association model on a specific disease
and given that it is able to reliably-identify the disease-related genes, can our
complex-detection method, ProRank+, generate substantial groupings of those genes
from a PPI network? To answer this question, we consider the breast cancer case
study. This disease develops in breast tissues and it is actually the highest occurring
cancer type in women worldwide (World Health Organization, 2014). Indeed, it is
important to identify the key players as well as the cellular events which lead to the
formation of this malady. We start by validating the reliability of our model in
identifying the genes related to breast cancer. Once confirmed, we apply the
ProRank+ algorithm (Hanna & Zaki, Detecting protein complexes in protein
interaction networks using a ranking algorithm with a refined merging procedure,
2014) to potentially detect protein clusters that can be associated to breast cancer.
6.2 Identifying Genes Related to Breast Cancer
From the OMIM database (McKusick, 2007), we get the list of genes related
to breast cancer (OMIM: 114480). We refer to the Human Protein Reference
Database (HPRD) (Prasad et al., 2009) and download the up-to-date Human PPI
dataset. Then, we compute the topological features and collect the biological
attributes to form the corresponding learning data. It consists of 9167 genes out of
which 23 breast cancer genes are covered. We use the Naïve Bayes classifier (John &
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Langley, 1995) with a 10-fold cross-validation to generate the learning model. The
resultant confusion matrix is presented in Table 12.
Classified as
Non-Breast Cancer Genes
Breast Cancer Genes

Non- Breast Cancer
Genes
8973
10

Breast Cancer
Genes
171
13

Table 12: The confusion matrix showing the number of correctlyclassified and the incorrectly-classified instances per class in our breast
cancer case study.
Although the learning dataset is unbalanced, i.e. the number of disease genes
Top 24 disorders
cancer,genes;
given our
by model
is veryTable
small 840:
in comparison
with the similar
numbertoofbreast
non-disease
MimMiner.Table 841: The confusion matrix showing the number of
correctly-classified
and thegenes
incorrectly-classified
instances
class complexin
identifies
13 of the breast cancer
(56.5%). In comparison,
theper
protein
our breast cancer case study.
prioritization method by Chen et al. (Chen, Jacquemin, Zhang, & Jiang, 2014) ranks
6 breast cancer genes in the top ten complexes. Considering the classes unbalance
Table 842: Top 24 disorders similar to breast cancer, given by
and examining the results, we canMimMiner.
infer that our model has a relatively good
performance.
Table 843: Groupings of genes associated to breast cancer and similar
6.3 Detecting
Protein
Complexes
using ProRank+
phenotypes,
detected
by ProRank+
and numbered by their decreasing
percentage of disease genes that they contain.Table 844: Top 24
disorders similar to breast cancer, given by MimMiner.Table 845: The
Considering the performance of our model, we then apply the ProRank+
confusion matrix showing the number of correctly-classified and the
incorrectly-classified
instances
per class detect
in our groupings
breast cancer
case cancer
algorithm
(Hanna & Zaki, 2014)
to potentially
of breast
study.
genes in the same PPI network downloaded from HPRD. Various studies noted the
fact that genes related to the same or similar diseases are often close to one another
Table 846: Top 24 disorders similar to breast cancer, given by
MimMiner.Table
847: The
confusion
matrix showing
the 2006)
number
in a PPI
network, for example
(Oti,
Snel, Huynen,
& Brunner,
andof (Oti &
correctly-classified and the incorrectly-classified instances per class in
Brunner,
viewcase
of that,
we refer to the MimMiner (van Driel et a., 2006)
our2007).
breast In
cancer
study.
tool which uses many text-mining algorithms to compute the similarities among
848: Top
24 disorders
similar to(McKusick,
breast cancer,
givenGiven
by a query
phenotypes Table
contained
in the
OMIM database
2007).
MimMiner.
disease, in our case breast cancer, MimMiner returns the related phenotypes along
Table 849: Groupings of genes associated to breast cancer and similar
phenotypes, detected by ProRank+ and numbered by their decreasing
percentage of disease genes that they contain.Table 850: Top 24
disorders similar to breast cancer, given by MimMiner.
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with the similarity scores and the causal genes of each phenotype. We select the top
24 disorders similar to breast cancer and generate the set of associated genes to all of
them. The considered disorders are listed in Table 13.
OMIM
No.
114480
176807
113705
120435
155720
151623
259500
278700
208900
256700
102660
603737
180200
260350
300068
305700
273300
188550
211410
139300
158350
210900
194070
211980
151410

OMIM Title
Breast Cancer
Prostate Cancer
Breast Cancer, Type 1
Colon Cancer, Familial Nonpolyposis, Type 1
Melanoma, Uveal
Li-Fraumeni Syndrome
Osteogenic Sarcoma
Xeroderma Pigmentosum, Complementation Group
A
Ataxia-Telangiectasia
Neuroblastoma
Adamantinoma Of Long Bones
Ovarian Germ Cell Cancer
Retinoblastoma
Pancreatic Carcinoma
Androgen Insensitivity Syndrome
Germinal Cell Aplasia
Testicular Tumors
Thyroid Carcinoma, Papillary
Breast Cancer, Ductal, 1
Gynecomastia, Hereditary
Cowden Disease
Bloom Syndrome
Wilms Tumor 1
Lung Cancer
Breakpoint Cluster Region

Similarity
Score
1.0000
0.5108
0.4996
0.4560
0.4402
0.4383
0.4205
0.4152
0.4100
0.4093
0.4044
0.4039
0.4030
0.3909
0.3904
0.3877
0.3862
0.3853
0.3845
0.3834
0.3822
0.3794
0.3783
0.3745
0.3732

Table 13: Top 24 disorders similar to breast cancer, given by MimMiner.
Genes in this set are used as seeds to protein complex-formation by
Table 905: Groupings of genes associated to breast cancer and similar
ProRank+
when applied
on the
PPIand
dataset.
Note that
protein
interactions are
phenotypes,
detected
byHuman
ProRank+
numbered
by their
decreasing
percentage of disease genes that they contain.Table 906: Top 24 disorders
pruned using the PE
method
(Zaki,cancer,
Efimov,
& Berengueres,
similar
to breast
given
by MimMiner.2013). Since we are
interested in complexes including as much disease genes as possible, we set the
minimum
complex
size generated
by ProRank+
Thecancer
total number
of detected
Table
907: Groupings
of genes
associated to
to 5.
breast
and similar
phenotypes, detected by ProRank+ and numbered by their decreasing
percentage of disease genes that they contain.Table 908: Top 24 disorders
similar to breast cancer, given by MimMiner.
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complexes is 113. Among those entities, 12 are shortlisted since the percentage of
disease genes that they include is greater or equal to 30%. Those complexes are
presented in Table 14, ordered by their decreasing percentage of breast cancer genes.
Complex
Breast Cancer Genes in the Detected Complex
No.
1
2
3
4
5
6
7
8
9
10
11
12

BRCA1, BRCA2, ATM, TP53, RAD51
BRCA1, TP53, MSH2, ATM, CHEK2
BRCA1, BRCA2, TP53, RAD51
BRCA1, TP53, MSH2, CHEK2
BRCA1, TP53, XPA, ATM, RAD51, CHEK2
BRCA1, TP53, RB1
BRCA1, BRCA2, TP53, BARD1, ATM, RB1, AR,
RAD51, CHEK2
BRCA1, WT1, BRCA2, TP53, BARD1, ATM,
PTEN, PPM1D, RAD51, CHEK2, BCR
AR, HIP1, RB1
EPHB2, EGFR, BCR
BRCA1, EGFR, RB1, PTEN, AR, RNASEL
BRCA1, AR, RB1

Percentage of
Breast Cancer
Genes
100%
83.3%
80%
80%
75%
60%
52.9%
37.9%
37.5%
33.3%
31.6%
30%

Table 14: Groupings of genes associated to breast cancer and similar
phenotypes, detected by ProRank+ and numbered by their decreasing percentage
of disease genes that they contain.
Figure 17 displays three of those twelve complexes. They respectively
Figure 540:
Detected
groupings
of proteins
as Table
detected
by addition,
the ProRank+
correspond
to complex
numbers
8, 7 and
5; based on
14. In
we show
algorithm. Circular nodes correspond to proteins among which the ones
to breast
and
phenotypes
are they
colored.
Hexagonal nodes
theassociated
associations
of the cancer
genes to
thesimilar
phenotypes
in which
are involved.
correspond to phenotypes given by their OMIM numbers. Interactions among
the proteins are based on the PPI dataset. Interconnections among phenotypes
correspond to their similarities based on MimMiner. The dotted lines correspond
to the association of disease genes to various phenotypes.Table 940: Groupings
of genes associated to breast cancer and similar phenotypes, detected by
ProRank+ and numbered by their decreasing percentage of disease genes that
they contain.

Figure 541: Detected groupings of proteins as detected by the ProRank+
algorithm. Circular nodes correspond to proteins among which the ones
associated to breast cancer and similar phenotypes are colored. Hexagonal nodes
correspond to phenotypes given by their OMIM numbers. Interactions among
the proteins are based on the PPI dataset. Interconnections among phenotypes
correspond to their similarities based on MimMiner. The dotted lines correspond
to the association of disease genes to various phenotypes.Table 941: Groupings
of genes associated to breast cancer and similar phenotypes, detected by
ProRank+ and numbered by their decreasing percentage of disease genes that
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Figure 17: Detected groupings of proteins as detected by the ProRank+
algorithm. Circular nodes correspond to proteins among which the ones
associated to breast cancer and similar phenotypes are colored. Hexagonal nodes
correspond to phenotypes given by their OMIM numbers. Interactions among the
proteins are based on the PPI dataset. Interconnections among phenotypes
correspond to their similarities based on MimMiner. The dotted lines correspond
to the association of disease genes to various phenotypes.
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6.4 Conclusion
Considering the case of breast cancer, our learning model reliably identifies
most of the genes related to this disease and the top 24 similar disorders. In view of
that, we apply the ProRank+ algorithm and successfully detect groupings of those
disease genes in the PPI network. Out of the 113 complexes generated by ProRank+,
twelve have more than 30% of their protein members related to breast cancer and
comparable diseases. Our results support the usability and the reliability of the
presented solutions in this dissertation. Namely, given a set of proteins reported as
disease-related, the detected entities by ProRank+ may highly-likely include proteins
which can also be related to the considered disorders. Therefore, such proteins can be
subject to further experimental examination.
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Chapter 7: Conclusion
Looking at a protein-protein interaction network, a reliable computational
approach can identify proteins and subsequently protein groupings that are possibly
engaged in certain functions or phenotypes, for further experimental examinations.
The proposed methodology in this dissertation is divided into three main
contributions.
First, we present ProRank+, an effective method for the detection of protein
complexes in PPI networks. It is based on a ranking algorithm which orders proteins
by their importance in the network. It also applies a merging procedure to refine the
detected complexes. In addition, our method accounts for the fact that a protein can
participate in multiple cellular functions by belonging to several complexes. The
method is tested on weighted and unweighted yeast datasets, as well as human PPI
data. When compared to several state-of-the-art approaches, our algorithm is able to
detect more complexes with better evaluation scores. Additional examinations and
modeling of biological structures and properties of PPI networks and protein
complexes could further improve the ProRank+ method.
Second, since protein interactions are usually subject to various temporal,
spatial and contextual settings, we introduce a novel way to model the dynamic
aspect of PPI networks. Genes which exhibit similar expression patterns across
various conditions most likely interact. Hence, we apply biclustering techniques to
analyze time-series gene expression data in order to group genes by their expression
patterns across different subsets of conditions. Then, we detect protein complexes
according to the generated groupings. In terms of experimental results, our
framework allows the detection of more protein complexes with higher quality
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scores. Our approach can be extended by integrating other biological data with PPI
networks such as gene ontology annotations and subcellular localizations to better
reproduce the dynamics of protein interaction networks.
Third, we present a classification model which integrates PPI network
topology attributes and numerous biological features to identify disease-related
genes. The experimental results validate our hypothesis that

combining

computationally-conveyed network study and experimentally-generated biological
information can enhance the gene-disease association process. The approach
identifies 65.2% of the genes related to the Diabetes Mellitus, Type II disease which
is a better percentage than existing experiments. Based on the attained results,
contributions from additional gene features may be examined. Moreover, the
presented approach can be extended by exploring various diseases and ultimately
linking the outcomes to drug design. Finally, we present a comprehensive study of
breast cancer. Our learning model recognizes most of the genes associated to this
disease and the top 24 related disorders. Then, we apply the ProRank+ algorithm to
detect groupings of those genes in the PPI network.
The generated results are in favor of our approaches, they support their
reliability and usability to analyze protein interaction networks and potentially
discover previously-unknown biological facts. In terms of future research directions,
our plan includes: (1) Integrating additional biological data and refining the modeling
of PPI dynamics towards better detection of protein complexes; (2) Working closer
to biology to potentially explore specific diseases using our approaches, in the
direction of identifying and validating the associations of genes and protein
complexes; (3) Computationally and biologically examining the extent at which
various attributes used in our approaches influence the association of genes to

79

diseases; (4) Finally, developing comprehensive and flexible tools which allow the
convenient use of the presented methods in this dissertation.
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